0000070318-26-000023.txt : 20260430 0000070318-26-000023.hdr.sgml : 20260430 20260430064701 ACCESSION NUMBER: 0000070318-26-000023 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20260430 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TENET HEALTHCARE CORP CENTRAL INDEX KEY: 0000070318 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-GENERAL MEDICAL & SURGICAL HOSPITALS, NEC [8062] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 952557091 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-07293 FILM NUMBER: 26919930 BUSINESS ADDRESS: STREET 1: 14201 DALLAS PARKWAY CITY: DALLAS STATE: TX ZIP: 75254 BUSINESS PHONE: 469-893-2200 MAIL ADDRESS: STREET 1: 14201 DALLAS PARKWAY CITY: DALLAS STATE: TX ZIP: 75254 FORMER COMPANY: FORMER CONFORMED NAME: NATIONAL MEDICAL ENTERPRISES INC /NV/ DATE OF NAME CHANGE: 19920703 8-K 1 thc-20260430.htm 8-K thc-20260430
0000070318false00000703182026-04-302026-04-300000070318exch:XNYSus-gaap:CommonStockMember2026-04-302026-04-300000070318exch:XNYSus-gaap:SeniorNotesMember2026-04-302026-04-30


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 _______________
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
 _______________
Date of Report: April 30, 2026
(Date of earliest event reported)
 _______________
TENET HEALTHCARE CORPORATION
(Exact name of registrant as specified in its charter)
 
Nevada
 1-7293 95-2557091
(State of Incorporation) (Commission File Number) (IRS Employer
Identification Number)
14201 Dallas Parkway
Dallas, TX 75254
(Address of principal executive offices, including zip code)
(469) 893-2200
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading
Symbol(s)		Name of each exchange
on which registered
Common stock, $0.05 par valueTHCNYSE
6.875% Senior Notes due 2031THC31NYSE
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging Growth Company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02.Results of Operations and Financial Condition.
The information contained herein is being furnished pursuant to Item 2.02 of Form 8-K, “Results of Operations and Financial Condition.” This information shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
On April 30, 2026, Tenet Healthcare Corporation (the “Company”) issued a press release reporting the financial results of the Company for the quarter ended March 31, 2026. A copy of the press release is attached to this report as Exhibit 99.1 and incorporated herein by reference.

Item 9.01.Financial Statements and Exhibits.
 
(d)Exhibits
Exhibit No.Description
99.1 
104 Cover Page Interactive Data File (embedded within the inline XBRL document)





SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
TENET HEALTHCARE CORPORATION
Date: April 30, 2026
By:/s/ R. SCOTT RAMSEY
R. Scott Ramsey
Senior Vice President, Controller

 EX-99.1 2 thc-20260331ex991earningsr.htm EX-99.1 Document

Exhibit 99.1
tenethealthrgba.jpg

Tenet Reports Strong First Quarter 2026 Results

•Net income available to common shareholders in first quarter 2026 was $702 million, or $8.01 per diluted share

•Adjusted diluted earnings per share1 increased 10.6% to $4.82 in first quarter 2026 compared to $4.36 in first quarter 2025

•Consolidated Adjusted EBITDA1 in first quarter 2026 was $1.162 billion; First quarter 2026 Adjusted EBITDA margin was 21.6%

•First quarter 2026 Ambulatory Care Adjusted EBITDA of $484 million increased 6.1% over first quarter 2025

•FY 2026 Adjusted EBITDA Outlook continues to be in the range of $4.485 billion to $4.785 billion



DALLAS — April 30, 2026 — Tenet Healthcare Corporation (Tenet) (NYSE: THC) today announced its results for the quarter ended March 31, 2026.

"We delivered strong results in both the Ambulatory and Hospital segments in the first quarter of 2026, characterized by disciplined operations and strong free cash flow," said Saum Sutaria, M.D., Chairman and Chief Executive Officer of Tenet. "We continue to support our physician partners to drive innovation in patient care as we execute on our high acuity strategy and grow our businesses both organically and inorganically."











Page 1

Tenet’s results for first quarter 2026 versus first quarter 2025 are as follows:

Three Months Ended March 31,
($ in millions, except per share results)20262025
Net operating revenues7
$5,368
$5,223
Net income available to Tenet common shareholders
$702
$406
Net income available to Tenet common shareholders per diluted share
$8.01
$4.27
Adjusted EBITDA1
$1,162
$1,163
Adjusted diluted earnings per share1
$4.82$4.36

•Net income available to the Company’s common shareholders in first quarter 2026 was $702 million, or $8.01 per diluted share, versus $406 million, or $4.27 per diluted share, in first quarter 2025.

•Adjusted EBITDA1 in first quarter 2026 was $1.162 billion compared to $1.163 billion in first quarter 2025, reflecting strong growth in same facility revenue and disciplined expense management offset by unfavorable payer mix due to lower exchange admissions.

•In the first quarter of 2026, the Company recognized an approximate $40 million favorable non-recurring pre-tax impact associated with the recognition of previously deferred revenue, and $413 million of revenue ($314 million after-tax) from early contract conclusion, both in connection with the recently announced agreement with CommonSpirit Health. First quarter 2025 results included a $40 million favorable pre-tax impact for additional Medicaid supplemental revenues related to prior years. First quarter 2026 results did not include favorable impacts for additional Medicaid supplemental revenues related to prior years.




Page 2

Balance Sheet and Cash Flows

•Net cash flows provided by operating activities for the three months ended March 31, 2026 were $1.641 billion versus $815 million for the three months ended March 31, 2025.

•The Company produced adjusted free cash flow1 of $978 million for the three months ended March 31, 2026 versus $678 million for the three months ended March 31, 2025.

•In the three months ended March 31, 2026, the Company repurchased 1.35 million shares of common stock for $318 million.

•The Company’s ratio of net debt to Adjusted EBITDA1 was 2.24x at March 31, 2026 compared to 2.25x at December 31, 2025.



Recent Transaction

•On January 27, 2026, we entered into an agreement with CommonSpirit Health ("CommonSpirit") relating to Conifer Health Solutions, LLC ("Conifer") whereby the parties agreed to the following terms: (i) Payments related to the early conclusion of the contract totaling $1.9 billion from CommonSpirit to Tenet in annual installments over the next three years (of such amount $540 million was satisfied on January 27, 2026), and in addition (ii) the reduction of Tenet's redeemable non-controlling interest of $846 million and an increase to Tenet's additional paid in capital of $306 million (associated with the redemption by Conifer of CommonSpirit's minority equity interest in Conifer), in exchange for a payment by Conifer of $540 million.

•The redemption was retroactively effective January 1, 2026 and the $540 million payment was satisfied on January 27, 2026 by offsetting the $540 million due to Conifer by CommonSpirit as described above. During the quarter ended March 31, 2026, this transaction also resulted in a non-recurring favorable adjustment to net operating revenues of approximately $40 million and $413 million of revenue ($314 million after-tax) from early conclusion of the contract.



Page 3

Ambulatory Care (Ambulatory) Segment

Tenet’s Ambulatory business segment is comprised of the operations of United Surgical Partners International (USPI). As of March 31, 2026, USPI had interests in 541 ambulatory surgery centers (407 consolidated) and 26 surgical hospitals (eight consolidated) in 37 states.

Three Months Ended March 31,
Ambulatory segment results ($ in millions)
20262025
Revenues
Net operating revenues$1,320$1,194
Same-facility system-wide net patient service revenues2
$2,095$1,990
Changes versus the Prior-Year Period
Same-facility system-wide net patient service revenues5.3 %6.8 %
Same-facility system-wide net patient service revenue per case5.6 %9.1 %
Same-facility system-wide surgical cases2
(0.3)%(2.1)%
Same-facility system-wide surgical cases on same-business day basis2
(0.3)%(0.6)%
Adjusted EBITDA, Margins and NCI
Adjusted EBITDA
$484
$456
Adjusted EBITDA margin
36.7%
38.2%
Adjusted EBITDA less NCI
$291
$279

•First quarter 2026 net operating revenues increased 10.6% compared to first quarter 2025 driven by strong growth in consolidated same-facility net patient service revenues, acquisitions of facilities, and increased service lines.

•Surgical business same-facility system-wide net patient service revenues increased 5.3% in first quarter 2026 compared to first quarter 2025, with cases down 0.3% and net revenue per case up 5.6%. Net revenue per case growth was driven by higher acuity and favorable service mix.

•First quarter 2026 Adjusted EBITDA increased 6.1% compared to first quarter 2025, due to strong growth in same-facility net patient service revenues, disciplined expense management, and contributions from acquisitions.








Page 4

Hospital Operations and Services (Hospital) Segment
Tenet’s Hospital business segment is primarily comprised of acute care and specialty hospitals, imaging centers, ancillary outpatient facilities, micro-hospitals and physician practices. It also provides comprehensive end-to-end and focused point services, including hospital and physician revenue cycle management, patient communications and engagement support and value-based care solutions.

Three Months Ended March 31,
Hospital segment results ($ in millions)
20262025
Revenues
Net operating revenues7
$4,048
$4,029
Same-hospital net patient service revenues3
$3,458
$3,491
Same-Hospital Volume Changes versus the Prior-Year Period
Admissions
0.2%
4.4%
Adjusted admissions4
0.6%
2.9%
Outpatient visits (including outpatient ER visits)
(3.7)%
0.7%
Emergency Room visits (inpatient and outpatient)
(3.2)%
1.4%
Hospital surgeries
(0.9)%
(1.4)%
Adjusted EBITDA
Adjusted EBITDA
$678
$707
Adjusted EBITDA margin
16.7%
17.5%

•First quarter 2026 net operating revenues increased 0.5% from first quarter 2025 due to an increase in adjusted admissions offset by unfavorable payer mix due to lower exchange admissions.

•Same-hospital net patient service revenue per adjusted admission decreased 1.5% year-over-year for first quarter 2026 primarily due to the absence of a $40 million favorable pre-tax impact for additional Medicaid supplemental revenues related to prior years recorded in first quarter 2025 and unfavorable payer mix related to lower exchange admissions. First quarter 2026 results did not include favorable impacts for additional Medicaid supplemental revenues related to prior years.

•Adjusted EBITDA in first quarter 2026 was $678 million compared to $707 million in first quarter 2025, reflecting the same dynamics as above, partially offset by expense efficiencies.

•In the first quarter of 2026, the Company recognized an approximate $40 million favorable non-recurring pre-tax impact associated with the recognition of previously deferred revenue in connection with the recently announced agreement with CommonSpirit Health. This impact is not reflected in same-hospital net patient service revenue.






Page 5

2026 Outlook1

Tenet’s Outlook for full year 2026 (consolidated and by segment) follows. Revenue recognized from the early conclusion of the CommonSpirit contract is not included in net operating revenues.

CONSOLIDATED ($ in millions, except per share amounts)
FY 2026 Outlook
Net operating revenues7
$21,500 to $22,300
Net income available to Tenet common stockholders
$2,605 to $2,840
Adjusted EBITDA
$4,485 to $4,785
Adjusted EBITDA margin
20.9% to 21.5%
Diluted income per common share
$29.94 to $32.64
Adjusted net income
$1,425 to $1,625
Adjusted diluted earnings per share
$16.38 to $18.68
Equity in earnings of unconsolidated affiliates$265 to $275
Depreciation and amortization
$875 to $925
Interest expense
$800 to $810
Income tax expense5
$985 to $1,060
Net income available to NCI
$910 to $960
Weighted average diluted common shares
~87 million
Net cash provided by operating activities
$3,640 to $4,090
Adjusted net cash provided by operating activities
$3,200 to $3,600
Capital expenditures
$700 to $800
Free cash flow
$2,940 to $3,290
Adjusted free cash flow
$2,500 to $2,800
NCI cash distributions$900 to $970
















Page 6

Ambulatory Segment ($ in millions)
FY 2026 Outlook
Net operating revenues$5,500 to $5,700
Adjusted EBITDA$2,130 to $2,230
NCI$865 to $895
Adjusted EBITDA less NCI$1,265 to $1,335
Changes versus prior year6:
Same-facility system-wide revenuesUp 3.0% to 6.0%

Hospital Segment ($ in millions)
FY 2026 Outlook
Net operating revenues7
$16,000 to $16,600
Adjusted EBITDA$2,355 to $2,555
NCI$45 to $65
Changes versus prior year6:
Inpatient admissionsUp 1.0% to 2.0%
Adjusted admissionsUp 1.0% to 2.0%




Management’s Webcast Discussion of Results
Tenet management will discuss the Company’s first quarter 2026 results in a webcast scheduled for 10:00 a.m. Eastern Time (9:00 a.m. Central Time) on April 30, 2026. Investors can access the webcast through the Company’s website at www.tenethealth.com/investors.

The slide presentation associated with the webcast referenced above, a copy of this earnings press release, and a related supplemental financial disclosures document will be available on the Company’s Investor Relations website on April 30, 2026.



Page 7

Cautionary Statement
This release contains “forward-looking statements” - that is, statements that relate to future, not past, events. In this context, forward-looking statements often address the Company’s expected future business and financial performance and financial condition, and often contain words such as “expect,” “anticipate,” “assume,” “believe,” “budget,” “estimate,” “forecast,” “intend,” “plan,” “predict,” “project,” “seek,” “see,” “target,” or “will.” Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Particular uncertainties that could cause the Company’s actual results to be materially different than those expressed in the Company’s forward-looking statements include, but are not limited to the factors disclosed under “Forward-Looking Statements” and “Risk Factors” in our Form 10-K for the year ended December 31, 2025 and other filings with the Securities and Exchange Commission.

Footnotes
1.Tables and discussions throughout this earnings release include certain financial measures, including those related to our full year 2026 Outlook, that are not in accordance with accounting principles generally accepted in the United States of America (GAAP). Reconciliations of GAAP measures to the Adjusted (non-GAAP) measures used are detailed in Tables #1-6 included at the end of this earnings release. Management’s reasoning for the use of these non-GAAP measures and descriptions of the various non-GAAP measures are included in the Non-GAAP Financial Measures section of this earnings release.
2.Same-facility system-wide revenues and statistical information include the results of the facilities in which the Ambulatory segment has an investment that are not consolidated by Tenet. To help analyze the segment’s results of operations, management uses system-wide measures, which include revenues and cases of both consolidated and unconsolidated facilities.
3.For 2026, same-hospital revenues and statistical data include those for hospitals and hospital-affiliated outpatient centers operated by the Company’s Hospital segment continuously from January 1, 2025 through March 31, 2026. Amounts associated with physician practices are excluded.
4.Adjusted admissions represent actual patient admissions adjusted to include outpatient services provided by facilities in our Hospital segment by multiplying actual patient admissions by the sum of gross inpatient revenues and outpatient revenues, then dividing that result by gross inpatient revenues.
5.Income tax expense is calculated by multiplying 24% (the federal corporate tax rate of 21% plus an estimate of state taxes) by the sum of: pretax income less GAAP facility level NCI expense plus permanent differences, and non-deductible interest expense.
6.Change versus prior year is presented on a same-facility system-wide basis for USPI Ambulatory surgical cases and on a same-hospital basis for hospital statistics.
7.Revenue recognized from the early conclusion of the CommonSpirit contract is not included in net operating revenues.



Page 8

About Tenet Healthcare
Tenet Healthcare Corporation (NYSE: THC) is a diversified healthcare services company headquartered in Dallas. Our care delivery network includes United Surgical Partners International, the largest ambulatory platform in the country, which operates ambulatory surgery centers and surgical hospitals. We also operate a national portfolio of acute care and specialty hospitals, other outpatient facilities, a network of leading employed physicians and a global business center in Manila, Philippines. Our Conifer Health Solutions subsidiary provides revenue cycle management and value-based care services to hospitals, health systems, physician practices, employers and other clients. Across the Tenet enterprise, we are united by our mission to deliver quality, compassionate care in the communities we serve. For more information, please visit www.tenethealth.com.

Contact Information
Investor ContactMedia Contact
Will McDowellOlivia E. Nadler
469-893-2387469-893-6352
william.mcdowell@tenethealth.com
mediarelations@tenethealth.com



Page 9

Non-GAAP Financial Measures
The Company believes the non-GAAP measures described below are useful to investors and analysts because they present additional information on the Company’s financial performance. Investors, analysts, Company management and the Company’s Board of Directors utilize these non-GAAP measures, in addition to GAAP measures, to track the Company’s financial and operating performance and compare the Company’s performance to its peer companies, which use similar non-GAAP financial measures in their presentations and earnings releases. The Human Resources Committee of the Company’s Board of Directors also uses certain of these measures to evaluate management’s performance for the purpose of determining incentive compensation. Additional information regarding the purpose and utility of specific non-GAAP measures used in this release is set forth below.
•Adjusted EBITDA is defined by the Company as net income available (loss attributable) to Tenet common shareholders before (1) the cumulative effect of changes in accounting principles, (2) net loss attributable (income available) to noncontrolling interests, (3) income (loss) from discontinued operations, net of tax, (4) income tax benefit (expense), (5) gain (loss) from early extinguishment of debt, (6) other non-operating income (expense), net, (7) interest expense, (8) litigation and investigation benefit (costs), net of insurance recoveries, (9) net gains (losses) on sales, consolidation and deconsolidation of facilities, (10) impairment and restructuring charges and acquisition-related costs, (11) depreciation and amortization, (12) income (loss) from divested and closed businesses (i.e., health plan businesses) and (13) revenue from contract termination. Revenue from contract termination represents the present value of the $1.9 billion of consideration related to the early termination of Conifer’s revenue cycle services agreement with CommonSpirit (as further described in the Company’s Form 8-K dated February 2, 2026), net of amortization of an associated contract asset. Litigation and investigation costs excluded do not include ordinary course of business malpractice and other litigation and related expenses.
•Adjusted diluted earnings (loss) per share is defined by the Company as Adjusted net income available (loss attributable) to Tenet common shareholders, divided by the weighted average diluted shares outstanding in the reporting period.
•Adjusted net income available (loss attributable) to Tenet common shareholders is defined by the Company as net income available (loss attributable) to Tenet common shareholders before (1) income (loss) from discontinued operations, net of tax, (2) gain (loss) from early extinguishment of debt, (3) litigation and investigation benefit (costs), net of insurance recoveries, (4) net gains (losses) on sales, consolidation and deconsolidation of facilities, (5) impairment and restructuring charges and acquisition-related costs, (6) income (loss) from divested and closed businesses (i.e., health plan businesses), (7) revenue from contract termination and (8) the associated impact of these items on taxes and noncontrolling interests. Revenue from contract termination represents the present value of the $1.9 billion of consideration related to the early termination of Conifer’s revenue cycle services agreement with CommonSpirit (as further described in the Company’s Form 8-K dated February 2, 2026), net of amortization of an associated contract asset. Litigation and investigation costs excluded do not include ordinary course of business malpractice and other litigation and related expenses.
•Free Cash Flow is defined by the Company as (1) net cash provided by (used in) operating activities, less (2) purchases of property and equipment.
•Adjusted Free Cash Flow is defined by the Company as (1) Adjusted net cash provided by (used in) operating activities, less (2) purchases of property and equipment.
•Adjusted net cash provided by (used in) operating activities is defined by the Company as cash provided by (used in) operating activities prior to (1) payments for restructuring charges, acquisition-related costs and litigation costs and settlements, (2) net cash provided by (used in) operating activities from discontinued operations and (3) cash received for contract termination defined above.
The Company believes that Adjusted EBITDA is a useful measure, in part, because certain investors and analysts use both historical and projected Adjusted EBITDA, in addition to other GAAP and non-GAAP measures, as factors in determining the estimated fair value of shares of the Company’s common stock. Company management also regularly reviews the Adjusted EBITDA performance for each operating segment. The Company does not use Adjusted EBITDA to measure liquidity, but instead to measure operating performance.
The Company uses, and believes investors use, Free Cash Flow and Adjusted Free Cash Flow as supplemental non-GAAP measures to analyze cash flows generated from the Company’s operations. The Company believes these measures are useful to investors in evaluating its ability to fund distributions paid to noncontrolling interests or for acquisitions, purchasing equity interests in joint ventures or repaying debt.
These non-GAAP measures may not be comparable to similarly titled measures reported by other companies. Because these measures exclude many items that are included in the Company’s financial statements, they do not provide a complete measure of the Company’s operating performance. For example, the Company’s definitions of Free Cash Flow and Adjusted Free Cash Flow do not include other important uses of cash including (1) cash used to purchase businesses or joint venture interests, or (2) any items that are classified as Cash Flows from Financing Activities on the Company’s Consolidated Statement of Cash Flows, including items such as (i) cash used to repay borrowings, or (ii) distributions paid to noncontrolling interests. Accordingly, investors are encouraged to use GAAP measures when evaluating the Company’s financial performance.
See corresponding reconciliations of the non-GAAP financial measures referred to above to the most comparable GAAP financial measures in Tables #1 - 6 below.


Page 10

Tenet Healthcare Corporation
Financial Statements and Reconciliations
First Quarter Earnings Release
Table of Contents

Page 11


    
TENET HEALTHCARE CORPORATION
CONSOLIDATED STATEMENTS OF OPERATIONS
(Unaudited)
(Dollars in millions, except per share amounts)Three Months Ended March 31,
2026%2025%Change
Net operating revenues$5,368 100.0 %$5,223 100.0 %2.8 %
Revenue from contract termination413 7.7 %— — %100.0%
Equity in earnings of unconsolidated affiliates51 1.0 %56 1.1 %(8.9)%
Operating expenses:  
Salaries, wages and benefits2,174 40.5 %2,119 40.6 %2.6 %
Supplies961 17.9 %907 17.4 %6.0 %
Other operating expenses, net1,122 20.9 %1,090 20.9 %2.9 %
Depreciation and amortization229 4.3 %206 3.9 %
Impairment and restructuring charges, and acquisition-related costs24 0.5 %19 0.3 %
Litigation and investigation costs27 0.5 %17 0.3 %
Net gains on sales, consolidation and deconsolidation of facilities(1)— %(22)(0.4)%
Operating income1,296 24.1 %943 18.1 %
Interest expense(205)(204)
Other non-operating income, net41 26 
Income before income taxes1,132 765 
Income tax expense(226)(143)
Net income906 622 
Less: Net income available to noncontrolling interests204 216 
Net income available to Tenet Healthcare Corporation common shareholders$702 $406 
Earnings per share available to Tenet Healthcare Corporation common shareholders:
Basic$8.09 $4.31 
Diluted$8.01 $4.27 
Weighted average shares and dilutive securities outstanding (in thousands):
Basic86,801 94,242
Diluted87,596 95,019


Page 12

    
TENET HEALTHCARE CORPORATION
CONSOLIDATED BALANCE SHEETS
(Unaudited)
(Dollars in millions)March 31,December 31,
20262025
ASSETS
Current assets:
Cash and cash equivalents$2,967 $2,883 
Accounts receivable2,605 2,565 
Inventories of supplies, at cost343 348 
Assets held for sale62 62 
Other current assets2,379 1,991 
Total current assets
8,356 7,849 
Investments and other assets3,809 2,883 
Deferred income taxes84 84 
Property and equipment, at cost, less accumulated depreciation and amortization6,251 6,315 
Goodwill11,387 11,198 
Other intangible assets, at cost, less accumulated amortization1,316 1,348 
Total assets
$31,203 $29,677 
LIABILITIES AND EQUITY
Current liabilities:
Current portion of long-term debt$81 $79 
Accounts payable1,339 1,360 
Accrued compensation and benefits854 858 
Professional and general liability reserves303 276 
Accrued interest payable256 81 
Income tax payable236 — 
Other current liabilities3,083 1,809 
Total current liabilities
6,152 4,463 
Long-term debt, net of current portion13,128 13,092 
Professional and general liability reserves938 951 
Defined benefit plan obligations243 245 
Deferred income taxes199 240 
Other long-term liabilities1,693 1,713 
Total liabilities
22,353 20,704 
Commitments and contingencies
Redeemable noncontrolling interests in equity of consolidated subsidiaries2,137 2,956 
Equity:  
Shareholders’ equity:  
Common stock8 8 
Additional paid-in capital5,124 4,914 
Accumulated other comprehensive loss(179)(181)
Retained earnings5,117 4,415 
Common stock in treasury, at cost(5,256)(4,936)
Total shareholders’ equity4,814 4,220 
Noncontrolling interests
1,899 1,797 
Total equity 6,713 6,017 
Total liabilities and equity
$31,203 $29,677 






Page 13

    
TENET HEALTHCARE CORPORATION
CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
Three Months Ended
March 31,
(Dollars in millions)20262025
Net income$906 $622 
Adjustments to reconcile net income to net cash provided by operating activities:  
Depreciation and amortization229 206 
Deferred income tax expense (benefit)(40)4 
Stock-based compensation expense25 21 
Impairment and restructuring charges, and acquisition-related costs24 19 
Litigation and investigation costs27 17 
Net gains on sales, consolidation and deconsolidation of facilities(1)(22)
Equity in earnings of unconsolidated affiliates, net of distributions received29 5 
Amortization of debt discount and debt issuance costs5 6 
Net gains from the sale of investments and long-lived assets(1)— 
Other items, net2 2 
Changes in cash from operating assets and liabilities:  
Accounts receivable(28)(69)
Inventories and other current assets407 (108)
Income taxes259 132 
Accounts payable, accrued expenses and other current liabilities(145)24 
Other long-term liabilities— (8)
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements(57)(36)
Net cash provided by operating activities1,641 815 
Cash flows from investing activities:  
Purchases of property and equipment(180)(173)
Purchases of businesses or joint venture interests, net of cash acquired(121)(27)
Proceeds from sales of facilities and other assets2 11 
Proceeds from sales of marketable securities and long-term investments22 14 
Purchases of marketable securities and long-term investments(26)(17)
Other items, net(14)5 
Net cash used in investing activities(317)(187)
Cash flows from financing activities:  
Repayments of borrowings(33)(32)
Proceeds from borrowings14 1 
Repurchases of common stock(318)(348)
Distributions paid to noncontrolling interests(197)(189)
Proceeds from the sale of noncontrolling interests6 11 
Purchases of noncontrolling interests(549)(41)
Repayments of advances from managed care payers— (11)
Taxes paid related to net share settlement, net of proceeds from shares issued under stock‑based compensation plans(86)(32)
Other items, net(77)(7)
Net cash used in financing activities(1,240)(648)
Net increase (decrease) in cash and cash equivalents84 (20)
Cash and cash equivalents at beginning of period2,883 3,019 
Cash and cash equivalents at end of period$2,967 $2,999 
Supplemental disclosures:  
Interest paid, net of capitalized interest$(24)$(99)
Income tax payments, net$(8)$(7)


Page 14

    
TENET HEALTHCARE CORPORATION
SEGMENT REPORTING
(Unaudited)
Three Months Ended
March 31,
(Dollars in millions)20262025
Net operating revenues:   
Ambulatory Care$1,320 $1,194 
Hospital Operations and Services4,048 4,029 
Total$5,368 $5,223 
Equity in earnings of unconsolidated affiliates:  
Ambulatory Care$51 $54 
Hospital Operations and Services— 2 
Total$51 $56 
Adjusted EBITDA:  
Ambulatory Care$484 $456 
Hospital Operations and Services678 707 
Total$1,162 $1,163 
Adjusted EBITDA margins:
Ambulatory Care36.7 %38.2 %
Hospital Operations and Services16.7 %17.5 %
Total21.6 %22.3 %
Capital expenditures:
Ambulatory Care$32 $25 
Hospital Operations and Services148 148 
Total$180 $173 


Page 15

    
TENET HEALTHCARE CORPORATION
Additional Supplemental Non-GAAP disclosures
Table #1 – Reconciliations of Net Income Available to Tenet Healthcare Corporation Common Shareholders to Adjusted Net Income Available to Common Shareholders
(Unaudited)
Three Months Ended
March 31,
(Dollars in millions, except per share amounts)20262025
Net income available to Tenet Healthcare Corporation common shareholders$702 $406 
Less:
Revenue from contract termination413 — 
Impairment and restructuring charges, and acquisition-related costs  (24)(19)
Litigation and investigation costs(27)(17)
Net gains on sales, consolidation and deconsolidation of facilities1 22 
Tax and noncontrolling interests impact of above items (83)6 
Adjusted net income available to common shareholders$422 $414 
Diluted earnings per share$8.01 $4.27 
Less:
Revenue from contract termination4.71 — 
Impairment and restructuring charges, and acquisition-related costs(0.27)(0.20)
Litigation and investigation costs(0.31)(0.18)
Net gains on sales, consolidation and deconsolidation of facilities0.01 0.23 
Tax and noncontrolling interests impact of above items(0.95)0.06 
Adjusted diluted earnings per share$4.82 $4.36 
Weighted average basic shares outstanding (in thousands)86,801 94,242 
Weighted average dilutive shares outstanding (in thousands)87,596 95,019 


Page 16

    
TENET HEALTHCARE CORPORATION
Additional Supplemental Non-GAAP disclosures
Table #2 – Reconciliations of Net Income Available to Tenet Healthcare Corporation Common Shareholders to Adjusted EBITDA
(Unaudited)
Three Months Ended
March 31,
(Dollars in millions)20262025
Net income available to Tenet Healthcare Corporation common shareholders$702 $406 
Less:
Net income available to noncontrolling interests(204)(216)
Net income906 622 
Income tax expense(226)(143)
Other non-operating income, net41 26 
Interest expense(205)(204)
Operating income1,296 943 
Revenue from contract termination413 — 
Depreciation and amortization(229)(206)
Impairment and restructuring charges, and acquisition-related costs(24)(19)
Litigation and investigation costs(27)(17)
Net gains on sales, consolidation and deconsolidation of facilities1 22 
Adjusted EBITDA$1,162 $1,163 
Net operating revenues$5,368 $5,223 
Net income available to Tenet Healthcare Corporation common shareholders as a % of net operating revenues13.1 %7.8 %
Adjusted EBITDA as a % of net operating revenues (Adjusted EBITDA margin)21.6 %22.3 %



Page 17

    
TENET HEALTHCARE CORPORATION
Additional Supplemental Non-GAAP disclosures
Table #3 – Reconciliations of Net Cash Provided by Operating Activities to
Free Cash Flow and Adjusted Free Cash Flow
(Unaudited)
Three Months Ended
March 31,
(Dollars in millions)20262025
Net cash provided by operating activities$1,641 $815 
Purchases of property and equipment(180)(173)
Free cash flow$1,461 $642 
Net cash used in investing activities$(317)$(187)
Net cash used in financing activities$(1,240)$(648)
Net cash provided by operating activities$1,641 $815 
Less:
Payments for restructuring charges, acquisition-related costs, and litigation costs and settlements(57)(36)
Cash received for contract termination540 — 
Adjusted net cash provided by operating activities1,158 851 
Purchases of property and equipment(180)(173)
Adjusted free cash flow$978 $678 


Page 18

    
TENET HEALTHCARE CORPORATION
Additional Supplemental Non-GAAP disclosures
Table #4 – Reconciliations of Outlook Net Income Available to Tenet Healthcare Corporation Common Shareholders to Outlook Adjusted Net Income Available to Common Shareholders
(Unaudited)
FY 2026
(Dollars in millions, except per share amounts)LowHigh
Net income available to Tenet Healthcare Corporation common shareholders$2,605 $2,840 
Less:
Revenue from contract termination1,650 1,650 
Impairment and restructuring charges, acquisition-related costs, and litigation costs and settlements(1)
(100)(50)
Tax and noncontrolling interests impact of above items(370)(385)
Adjusted net income available to common shareholders$1,425 $1,625 
Diluted earnings per share$29.94 $32.64 
Less:
Revenue from contract termination18.96 18.96 
Impairment and restructuring charges, acquisition-related costs, and litigation costs and settlements
(1.15)(0.57)
Tax and noncontrolling interests impact of above items(4.25)(4.43)
Adjusted diluted earnings per share$16.38 $18.68 
Weighted average dilutive shares outstanding (in thousands)87,000 87,000 
(1) The figures shown represent the Company's estimate for restructuring charges plus the actual year-to-date results for impairment and restructuring charges, acquisition-related costs, and litigation costs and settlements. The Company does not generally forecast impairment charges, acquisition-related costs, and litigation costs and settlements because it does not believe that it can forecast these items with sufficient accuracy since some of these items are indeterminable at the time the Company provides its financial Outlook.
    






Page 19

    
TENET HEALTHCARE CORPORATION
Additional Supplemental Non-GAAP disclosures
Table #5 – Reconciliations of Outlook Net Income Available to Tenet Healthcare Corporation Common Shareholders to Outlook Adjusted EBITDA
(Unaudited)
FY 2026
(Dollars in millions)LowHigh
Net income available to Tenet Healthcare Corporation common shareholders$2,605 $2,840 
Less:
Net income available to noncontrolling interests(910)(960)
Income tax expense(985)(1,060)
Interest expense(810)(800)
Other non-operating income, net150 200 
Impairment and restructuring charges, acquisition-related costs, and litigation costs and settlements(1)
(100)(50)
Depreciation and amortization(875)(925)
Revenue from contract termination1,650 1,650 
Adjusted EBITDA$4,485 $4,785 
Net income available to Tenet Healthcare Corporation common shareholders$2,605 $2,840 
Net operating revenues$21,500 $22,300 
Net income available to Tenet Healthcare Corporation common shareholders as a % of net operating revenues12.1 %12.7 %
Adjusted EBITDA as a % of net operating revenues (Adjusted EBITDA margin)20.9 %21.5 %
(1) The figures shown represent the Company's estimate for restructuring charges plus the actual year-to-date results for impairment and restructuring charges, acquisition-related costs, and litigation costs and settlements. The Company does not generally forecast impairment charges, acquisition-related costs, and litigation costs and settlements because it does not believe that it can forecast these items with sufficient accuracy since some of these items are indeterminable at the time the Company provides its financial Outlook.



Page 20

    
TENET HEALTHCARE CORPORATION
Additional Supplemental Non-GAAP disclosures
Table #6 – Reconciliations of Outlook Net Cash Provided by Operating Activities
to Outlook Free Cash Flow and Outlook Adjusted Free Cash Flow
(Unaudited)
FY 2026
(Dollars in millions)LowHigh
Net cash provided by operating activities$3,640 $4,090 
Purchases of property and equipment(700)(800)
Free cash flow$2,940 $3,290 
Net cash provided by operating activities$3,640 $4,090 
Less:
Payments for restructuring charges, acquisition-related costs and litigation costs and settlements(1)
(100)(50)
Cash received for contract termination540 540 
Adjusted net cash provided by operating activities
3,200 3,600 
Purchases of property and equipment(700)(800)
Adjusted free cash flow(2)
$2,500 $2,800 
(1) The figures shown represent the Company's estimate for restructuring payments plus the actual year-to-date payments for restructuring charges, acquisition-related costs, and litigation costs or settlements. The Company does not generally forecast payments for acquisition-related costs, and litigation costs and settlements because it does not believe that it can forecast these items with sufficient accuracy since some of these items are indeterminable at the time the Company provides its financial Outlook.
(2) The Company’s definition of Adjusted Free Cash Flow does not include other important uses of cash including (1) cash used to purchase businesses or joint venture interests, or (2) any items that are classified as Cash Flows From Financing Activities on the Company’s Consolidated Statement of Cash Flows, including items such as (i) cash used to repay borrowings, and (ii) distributions paid to noncontrolling interests.


Page 21
 EX-101.SCH 3 thc-20260430.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Document and Entity Information Document link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 thc-20260430_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 5 thc-20260430_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Domain] Class of Stock [Domain] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entities [Table] Entities [Table] Entity Listings, Exchange [Axis] Entity Listings, Exchange [Axis] Class of Stock [Axis] Class of Stock [Axis] Security Exchange Name Security Exchange Name Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Cover [Abstract] Cover [Abstract] City Area Code City Area Code Common Stock [Member] Common Stock [Member] Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Entity Registrant Name Entity Registrant Name Trading Symbol Trading Symbol Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company New York Stock Exchange NEW YORK STOCK EXCHANGE, INC. [Member] 6.875% Senior Notes due 2031 Senior Notes [Member] Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications Local Phone Number Local Phone Number Exchange [Domain] Exchange [Domain] Title of 12(b) Security Title of 12(b) Security Document Period End Date Document Period End Date Entity Information [Line Items] Entity Information [Line Items] Document Type Document Type EX-101.PRE 6 thc-20260430_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 7 tenethealthrgba.jpg begin 644 tenethealthrgba.jpg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htm IDEA: XBRL DOCUMENT v3.26.1
Document and Entity Information Document
Apr. 30, 2026
Entity Information [Line Items]  
Entity Incorporation, State or Country Code NV
Entity File Number 1-7293
Entity Tax Identification Number 95-2557091
Entity Address, Address Line One 14201 Dallas Parkway
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75254
City Area Code 469
Local Phone Number 893-2200
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Entity Central Index Key 0000070318
Amendment Flag false
Entity Registrant Name TENET HEALTHCARE CORP
Document Type 8-K
Document Period End Date Apr. 30, 2026
New York Stock Exchange | Common Stock [Member]  
Entity Information [Line Items]  
Title of 12(b) Security Common stock, $0.05 par value
Trading Symbol THC
Security Exchange Name NYSE
New York Stock Exchange | 6.875% Senior Notes due 2031  
Entity Information [Line Items]  
Title of 12(b) Security 6.875% Senior Notes due 2031
Trading Symbol THC31
Security Exchange Name NYSE

XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 11 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 3 22 1 false 3 0 false 0 false false R1.htm 0000001 - Document - Document and Entity Information Document Sheet http://www.tenethealth.com/role/DocumentandEntityInformationDocument Document and Entity Information Document Cover 1 false false All Reports Book All Reports thc-20260430.htm thc-20260430.xsd thc-20260430_def.xml thc-20260430_lab.xml thc-20260430_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "thc-20260430.htm": { "nsprefix": "thc", "nsuri": "http://www.tenethealth.com/20260430", "dts": { "inline": { "local": [ "thc-20260430.htm" ] }, "schema": { "local": [ "thc-20260430.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/exch/2024/exch-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "thc-20260430_def.xml" ] }, "labelLink": { "local": [ "thc-20260430_lab.xml" ] }, "presentationLink": { "local": [ "thc-20260430_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 2, "axisCustom": 0, "memberStandard": 3, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 3, "elementCount": 32, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 27 }, "report": { "R1": { "role": "http://www.tenethealth.com/role/DocumentandEntityInformationDocument", "longName": "0000001 - Document - Document and Entity Information Document", "shortName": "Document and Entity Information Document", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:EntityIncorporationStateCountryCode", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "thc-20260430.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:EntityIncorporationStateCountryCode", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "thc-20260430.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonStockMember", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock [Member]", "label": "Common Stock [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "terseLabel": "Cover [Abstract]", "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitiesTable", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInformationLineItems", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityListingsExchangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityListingsExchangeAxis", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Listings, Exchange [Axis]", "label": "Entity Listings, Exchange [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_ExchangeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "ExchangeDomain", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Exchange [Domain]", "label": "Exchange [Domain]", "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "us-gaap_SeniorNotesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "SeniorNotesMember", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "6.875% Senior Notes due 2031", "label": "Senior Notes [Member]" } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "exch_XNYS": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/exch/2024", "localname": "XNYS", "presentation": [ "http://www.tenethealth.com/role/DocumentandEntityInformationDocument" ], "lang": { "en-us": { "role": { "terseLabel": "New York Stock Exchange", "label": "NEW YORK STOCK EXCHANGE, INC. [Member]" } } }, "auth_ref": [] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 16 0000070318-26-000023-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0000070318-26-000023-xbrl.zip M4$L#!!0 ( . UGESAXUL=FF0 C%!P > =&AC+3(P,C8P,S,Q97@Y M.3%E87)N:6YGK+DZSEN '?DYY:*YU*3^5] MJY)ZDO3I-9]FR2#'3&-P TXJ\^O/WA+XBFVPC1%8O6:J4D$(27MKWR^_#L.1 M\_'7(:/6Q__GU__WXH)\\LS)B+DA,7U&0V:126"[+^1/BP5_D8N+:-2--W[W M[9=A2 S-:),_/?\O^Y6*YZ$=.NQC/,^OOXA___H+_\BO?<]Z__BK9;\2V_K' M!UO7F-%I-VF[2]O-?K?3ZYFT9S8;+:/%+(TV_ZU_@%=AN'@G"-\=]H\/(]N] M&#+\_F6S-0ZOWFPK'%[JFO;3AX5Q(?L>7E#'?G$O^6KAZ;6'@'WG9LE\4;T0U<_>WWH=VW0]+KU?7%%4[7^?%7>_1"J!/B4ET6 MPKDZX=!_Z=/Z?\8O'TC@F^N>B!U$'^RVQM^O1M1_@V'HC2[Q+%^9']HF M=:(CX*U4&UTXU6<\#?+( MQIX?!N0I]#U Z=]M/PC)_TZH#\L1>/S(@HD3!IEWL7GO8VI9<(V[5@CLL+_,V!<$R+3X//^/*B44\@G7T:,)S@ MPT>]^%/_\!&O$/#T ,Y6U^KMG_ &_=BL=XTU=P9NUQA.W8K&-=J)XUKJNA1Q M76X\-_ EUO&Z0OF,C//[1Z5Y$8 ML3!T"1Y$"%E\!D.'FZ>N3!%7)@E0H_X$T-/SW\D-D+H5P'D#H'S=9BPUS%'0 M=EW_B7B R D4D1 %X$( _*_DZ_EN[:F@U<<[QPT/BP_+RFHG+$_K<9Z[>FGAQ;SP?=#N*'(><\:?GY.S^ M7T^W0*.[5^3Y\\TYP-.B[X2ZKC=Q3< .&U1!7RA\9 #J .)"?(T97#J+?*6^ M.8PVK8M-US->[F.>RL\_-)I7?S)B 3<%RH3ZC-!TXUT"PH,F/^0[G2-]U+7( M9R\8X^4C 7M!LTT0WXY%\@:W!$^A1DP0R*D)OX+U6:3_#F)[8-IC7)1%/!#9 M.2P"/G>TBH'/&#%I,"0#QWNK\=62@-H6>:*3$7F:A!3.H$:^UC_5:^1F2&U_ M1%T^P\W09@-R^YV9$Y0ER,-@8)MB.1S8=<14L?GXDN/U#29CU/B)-_')>/@> MV*8-$X)0&[JH*L((R\?I;,")5X$\-CX/;6X 0\0"EOW&".-?!B+A\KF&<.B$ MFA,[?,?-@0SV(D[QQ??>^(@^6LU8$ "MX2?N^2_419''$0-M=^XW=7$4!R84 MY7ZV9*OB5KY5F7*=W2\R9VFS5V@?Q&4 81I380;3SKX&QHVVL)UYZ3HJP6UA MWRAPNT3;HOASZ,_8V@N[Z(/ \]<%'< R+ZGS1M^#Q7,[O"FV$-K)R0AG:)VK M1;:0H H <0TF09+D%Y&,@>< B0LX\\EX)4)NW)KBL6\Q_P*V[M!QP"[C'ZZ MVHX=^GYINWPK_*6=;+F:5M<$K$)83FC%7XX>U_FC7T)K]5D'1.!6=^UC#03D M=<\V3:MK=:.S_O%>TQIIIX5S#L;4_<>'QM1H'I^XZZ&BFG7D+_QT_76O1 +D MI49T+CRNS-Y>&6J,O^/@JQ5BL@STD6U9#CL,B>EM$QYU/.+G(7+ZKS!N&)#; M!$EJBO:Y'&+"R:!@OF)UX/?@P.>R5HM9H3K\TIW]B )'I%T&-9 S3#8.9Q;/ MF!"=ISBQS(B1RP%L1 PDGI7926M'+"X]#,$59.<0_+%5:[2[ M^1X$WU6>]SHEML)>#:-1UJM]W%N=Y)(5EID$Q^Q^=+\<]Z2C&:EO21GN0E-+ MPZ[53Y"J6@_#H M-;U=+;:,.RJMB%K4_3QV6)FD=_;X2+SF6F+@V7YRCS3W$6/CCG,=?^&&?FGC M2M*ZJ0\>19+FPRLQ(_K&V&+T?=]@!*3[/G4+98\W%B;O%$''M=BIA$K78I0R M"II)+R1&8]:)]-%'9<22_,2\#O]"BG6MXQG=XT4>IX/W,0YICDP#H$WOQ>4!21@W-![[WG=[1$.&1'4: MPSF#*[#7"WAGXON(16,?_>C?B0V3F2&A0>"9-@^O?K.CF*GH SQ0"%8 ;[S: MWB1PWHG%!LQ')(Z0K<:Q[<>FWIA^%UZ(,?'LQX8^"RKEL17XZ7,R\+T12J@P M(\8Q8805_F ZDX"S QY+9..=<5U$?GA[?G& +LY\A!M]\9E ;#[JAK.OI['M MVW'P'+"+E;#8UER\&'P9W;<43W"!E\T=X]+!8A@S8)(_,Q'C. MWS'82;&^7'23:[4M$6X[\Z@#P;-?@2RP611SR -P@-9C ,[:4&8" M0@Q#D:O=U!=%KE@5Z>JM&=O,,C>H(0H=#HX.SW.R#N""->$\/M9,%L.KE8:R M24/!9(]>I[L;,J$=EZ M<,G_H>Z$^N_BLAB=F.5@+AGJR)A^Z,+M0CO55B,-.>,)8O-/^"_.A>4"E0"8 MZL9S[0'SXW>>T$ @HLJ_?+F93L''1&^_#6$AH$L@'\2D.%0A^&JLV $B\ECX M!Y@_$ODLA)S9Y^0;?1=I@G/&$WQC:KR*;%9(J/'W4W-6Z"'"PXR@>/06U0YN M_5K8_S2,RL8\0#A1!WX*8 )'?)PG8./T+F!?Q/>Y\8:#B3DD=.1-X&Q_ M;,V9 )$ !G!PP<#&;,4IM$@,J/-:E*4WM2+!IF'7PLX&@G=L N2K^Q\\!0N M.+4J\MW"V>$^;0[O(.1"9[?9GMG]7&ZGC'/*IYN%Z>9L5V.T6Z')CXK\3)RE M,7,1D;-D0Z7%1F.^2(!OC!GPZOSIPG=&F(>(-G+V-T]FG*X5/AB]=LH46<8^SBY/-GK.2AO.2A.=@B'OL,,(W; !A0")JS/%'D'8DQ@B/'W&6&Z2T6F+[=1[6U#W<7D.33Q(_G MVII[C1*['9!PQN<(=0(OL@LS<5^7K/HSV[!0E/E.89%N8E8"8O&YKX+Z@K@HP5%2JXPXO@TD@B./OCZ=O=.=#.:_Y6(J'$(61(K2E'YX$JK:8. M\M!TB0%\B,'?XJ*!S-34.DB2IH6ESCG) \(?Q$L:1F4B8# _A:7A\(U&!R ! M_PH23,#%:"$JHUIE5*N,ZG+'^*ZERLG1I7-T.":_RW'B*3W3$+J81P<%[$++1!0BJC!N" MXHIO,/FK;;+2%:DH:7I;,E/YT:AIO32<5ZJ]K$!3[$6O]7II")%,E_?84L0- M]RP$<50-VD6^81CNQ;\8].Q"OU\^Q@W8H\EX=#^5$P^20=*N=\L&E>2-K(>*HGZ'H'X\9=,$ M&:V-0R$>;&C3D/W-W?5M!3+5[[S!,U RWWE3J%L;[/;/(1S4;+- MKBODUVJGWJRZ[J=VW44P\ E<^D:[WOGI9&Y]HULWTN]677NU->D7K(@U<=!, MDDT=D)^ K9'1C%X5R[FOD=&,3N^8Q'JEXG*BY;"4E122.S_+E?"<4 5R3>;N MK#6[KM7;/RW4,$EHU,D;__+L^)7JL?,I;<+N.K71;@IVJA%J_CVQA7649^9% MK]G\&2\G$"\Q?A=/H71%8\N -],FTLTG HQ C^]'"Y")F/X5ONG.B'W28\C1,5L_1D28T=J&!#UI,:I9XGO M\9Y&]G>%:D& \M>L0L*R27"G"@F=#_$[JD+"8H6$SU&2/7F8E0? M^_HD;GE SN(1VPHF[(D36Q,E13TYF2LR3,\RJ1[#V+='U+=Y:9:YR@S 14,L MI>J+G@'!F)FP3""YT^H'-0(OOJ#\&=5.0((*=-G!)(SI\KP$.+)-W[N8 M%5# J^& L6YKOI+/*&>/58\'+B@A@U0T'FOL2] M$K"6NN>+*M"OU)G Q>4LCI];$%BOB!^->NMXP6_%A>P8S]J1E:9*YL19%U54TYK=;%E]/6ZM* 23YKWTR?=.RA#B69[/)-*Y9 M;R9MMNH7)7(YTY4;([MTDC[!0%WMI*O=/IVK;=1[IW>U'V;^Q%>,S0C(V:&,$[I0^BF*GS.'+.\I8A?LKBD/#JVM+=$[H2MS!GV&'0@Q,\GDGE!\C$?V(HLC[> C:G8,X+"7;[!HO04=+ MW7K%:Q!U^,6DPHD[2R(8:F1_CV=RO#?LU1OWA9Y-4+8R.+ +2 MX\;'VQ;-(')Y0 K^=(O5<4_DQ>NNC MINX^IDM9HM%S HZCT2X99^?F6X^WA"3WC/9^FB0#Q]D(A\-8#HP,'>ZU$W8W(5<'KJ..]SA#9.T&6#@6W"M8;_(SHJ7#@X+MRY'#B+\ -2 M%K>79]BR'F2W=TYK7ESX'J;9S3>%7V@)/R,#BVWGEZ@?#0+/M/F%Y[4 \$/1 M!\*H'3R\\6I[DP"I+1LP'S$O)NJB*(7+1,_[^1D I@[F^[O>!(@R+/7%9R(] MCX^"S8P\]VEL^W9(/C/JA$/ J^>A'<0K@Y^0K$7(*TAKD);;9&/U*M&[=(G> MK261?Z=$;UW[$+]TAK8QTYMSGH=)Z'C>7YLH9,9U=3BUV[ZRA'B==6N- M(WFZ&T-Y]!TN=N["[\1QN/0EY(!<&!6?)U7^'E_LV5&Y)?_D M0M$C%*3[T];9YW!,#HC-*))$R5CSW)%KG,B.X AY)CU*R$'$U2*..F-"O.;( M'..)Y&G.=Y(UW*R"4(D2Q8UVO6VT#IY]W>S56T;CX-,:6KW52I?4O:?A=9:I M'4$O@L=2UEST4$AXB8\VI-H=K*=]5IZQ:T_[FX?[IXT M0Y)Q0A/[&JK4#(X:#1#!D-?.&(%0&@;GZ>W,VP'JBP4< =A9I;!=3WUC:97? M_T621(2=#/9ENFEKE=FC&KUE2%'=O>5*^A35,E^[G!R@AEYK:1HW_1A&K:%I MI;YZHFE++P,DCGO)0 CT1L P7JGM<-D-SIT+[+P$$78_"CWSKZ'GP';7-Q56 M"+T)H6MMK27PN=9M*G0^4AUJA:R[)=,WNP)9F[5.=]D(I9"U\ X7"F=7,I.T M>N\G1%E#3XZ44!A[B&/^9*-UWHHE!EX4.1(14.=4J+N3;-"K]YJGN_ M=$R%O"G(K3N5>17"[H*P>JUI"/E K[4-)1_DCK!61'89]5U8>S"S\BD$W@F! MV_5&5R!PM]Y.'UBN$#C;0=_^S?LAV.X,<[T!F;B+WJ[!P'8P.$,VTT+^5253 M2PCMR';0::4X(X6E&85:-O:QQ#B/[D'?*QUYL*;_\E](AI,E(;#=CD#8GI(. M5DYDYK'/KI6O)J=!V%6UUP2=Z1T':RN+EG_P?J/7!6C#$.39M MS)N195,$RX&B/_^@&^VK[C11YO!H*EU>>*'+4)QFRFE,&@SC?ED\='D6MH5M MM5YY"RYUJ7DHSB&%SSGBLQ%IW(#9*JXOMX.^H2)]D*O6 MEAU.E%BUR$*DL#6W0_X=N^UQJCMPO#>%I[N%F/::,64UE*20OZ0P4$A[ M *2=QOG7%('-44N[N1.H"@N-[$<;V.MH^WOA,9;O4,U74 MHB)%+=I+1'[N3YGJ4Y0FB[W3J3>U9A[IYHU>.]6T6ZRTIY4G?CWJ3X!$>/X[ M>1(%'#:XM1M:2Q\8Z5>U0U=LOJB"NV(G)*RG[^E09JFYH*ST(UQ(J87=C8GC MDJ"://)L:ZJ#M6H=;5&F/7%,DCN=5!X4,FIZ(U;CC89"H47-6Z'-NN#+**Z] MVVLIE%F?%^RP() P
/-)K<8:$7FLT,N&2Q/$I14Y^FB')2]VJ9Y6ARQ*9 MW#[@0E.'G;6Z5\4K].9G7)*J MN%ENVV;Y!%=5*K/"HL6/>KNF119:^+&M3+3*1+N+B;;1BBM0MEK*WJ9,M.EJ M00J<:9^(4>TTQ0=E]SHENU=E35MW;MPH:]964!'VM?8J/;)7&?BW-.3]I(VS MUZL-894U=G_L7D7NPH.OIS&L"_94W-YAS"U[]T;[2EWZPGL93MMV_CY 3&QS:5ILFB]\??#H>]-7H:)>X Q("PQ0F&_ M;V_U$ ]A*+I,FM[HYQ^:G2L[GG^77I%'@AUV:W70 34&"&"?7E&(+Z%G9WPH M/G;H9*+CIFCK2H$NCM]%RS,[F"N4ZN.!@BR)W9=KHKK?M/GO0FO@@>U2%SXH MT,;Q LR8)99G3F8(U9^OIN.YB4")(0KWPN$[F<%I#1*HY 1YDA.639&+60%I M.VXV/LB7T2 ]P[FA/"F-8N \T V'SI?$&&RIZ2#-TZD-EQFWE 9/^:_4=^Z M0"\%VMR#>,D!'Z!?D0L@#Q0;+=;F'HK?"0*$TLE@@IGY-=Z+<0RDK4;0=A\& MR!D$*<,/PZ'5R/HO MD#VH_=SWVVAMUA&0#>7UA\D/0G >P7!B-%G)&^,?/A M,\!'3;;T!)8A>JL+(BJ^&!T*>0-A,0!R:@ZQTW9T0N*3M?@XHM]2%T1#&_0T MMO(D"(#4+O^V#QH^',G*KR?6"UN9' @O[Q&]_'O8$T/&L?Q[&X[6M99_"QJ+ MN_(['_O)KTPP]KW_)&PR8.ROA-\M_RJ$JSBW"> 9T0-D-O7XU[^OAWO_'8%M M^\2E'*HQ!L 9 (6)D(TB?@&J6?: <\V06 S;5 ->8M-J'R%8)]^P+[HY<:@_ M^RU6.1%SF-[$ =6#3N F)*$7-<,)($DL0<'7@%4B)'S1:WWV;9@.$=O#=NO? M.7<6S4<39;3U.X_ZEM8 D?D.^05R[)$=BH[QO,LXK HEJXB?PP-.;>)#CL_U M2S3[T\H-1D2/!C_:P5_D=S%A_!A6[4U\A,\(!,.+_\LE1/PP[V8+B,4LP>D_ M,9.-^O#EALY9?DM<(1CJ$ZQ]C8+*5,9YPB;FO, ,'W7[W>3&.=[&5:B$F_*) M^'\'IX2[B2C2N-Q3#M(X?'2, M.W@![V]:KF8:BX3/G MP\GG"XM*4.!!^@P\'#+BH)@>$?D.7,0H'FPL/$9D1&+ MCO>X<" @,HH+#S@V)"LMVI?Z6,S.HLPXVY $9T&JXF0=E"?$WF$<>;@68P$( M= Y5D5\@D8M?%"_$_[J8-AT!$CH)8[>1L#H$$18)1$P23*=QD#%RHR)DNQ,@ MB< _!KXW(O^'NA-496.)+[;C?:6^.8P,0'IL!;P6K;I7;%[CX7L VA)E9M<\_T(-4%G1@KUXGL!3AH/7+@F<\N*?X]2 M$BCP@#%V)&!QLP3249QYW71E1KB6) BWVO> H)F'.JA]1T1G'@6,YD_DC#-; M9J&$"L3&'Z-6(^;@/P &&/I/9.Q,.).-[2#X>ZXTXT@6G"\B#7=7H(44%!V#O8/KA=+G\,T B@<%RYX9P^JI]#OB,)Y!\%+0::;'HO+DQF"8F# MJX34!P$$E5&XHE.U2AB///=I;/NV$%90G$!4$2KR3%US$P/)E8M*(A?5MG26\#O.ZC;4K$#7SF/G-SOIWFSOO(,[YAMDZXT$(&P#M^=O^OIUO!S,GS MYYMSO-<413O@#?; AHL]G+TXE4M-H=/@,RL*@Q DX!-U'(K4^P'D4U,8I!R< M[!VIPYOG_Q53C&!J&HNY!7H17-2@>',REZ^/.ES8) YZ.T *H#,N,X:_T[#Z/QF!'[QX$CB1>#D$3@X^ MZ]@>DD=J FD1^^1SC;$5H .,0P_B8X'9'#A-I)QL-':\ M=SB:J0H71,$'+X[71]89.^#$1O $OE+7=FB-?!O"W.,Q/HZ@<..Y-HA8$0*0 M)R2'7 D()OT !'A4-",](XB)-C'?38?-&T'P^Z_4F0!AH&AK7,0'4&/F=BPP M)A(6X-\)FF@MWF0$!7%(IF,+_R6Y-KD2@7 5Z,LW"I(*!F*\,:[(3@3^8(5] MV&:DVW!GE4 Y#-!!J:4FT)4_IC&XID@S&N$\J%6]B0VA^1,-""./#YN:LF ? MPOK\:@-O20J:2:O@S%& DCI!;M!W"T+ W>QX"L\4[G7JNLC+S9HHW&S4V_KZ M9.!=$X6[]4:K=?!9F\UZIY$NJWE+L.RNF0='04">T#D-AXKP+44X:V)H>UGW M_Y4!>4[<_!%!>W"AA&_M3PR)^VI^\MZ8X\@+UWPV_P#\"0![6R?WU'*87RW0 M-MN]BVZO<6$TNIU3@VR\]W:C950+JAA69--1?61:_,[^_$.[>;4D ,D![>-% M^O&#&2&1]N-XW8W'LE2((%,>@3*,Y&H8Z2G#"$,KX9Z*P89HC91:3N-0UI'5 MS:Q/(8A\M"0*&!6*YVI\BHAFZ:/2R1SO36BA 1M,'.'(B],QN+*.,0CC.YFZ!BT1$+L4+;$F+2 QQG8N_Z,V_5IMNI4EW3UIVM\\ZO,HH$^VST2X MXR2T'5M$2B3%]-1X2%2T=MSSTE,,50(5_Z\MN^ :_]10O!PWS+5U/SE6='XL M'GF(OT++ 1]GSV(R\,0#&["$^K-MK,:)178 VU_('Q$07(XF"NH$<>7S!#Z/ MB4O>Q$?;!X^M#$/&YNSEVXZ9&Y=X7$D!)2S1X&&_[ZH!. MG71?7CJ)9KUG+,0A1$5?;:15@.TK42@88N\FM?<^<]#>1D/1WP=_=8X8*(QO M\_V5AYYCH=6NSS PGISIY\*0-AE-A Q"V& :(Y(8D:E :(XRI6XR1HY,\[Y M>E:^3LZ6E\C7 ]C&/5">XPC,%MYAG*EQ'N^*[^5<.+8PKM3C\37,6@CPXLZJ M ?JVX=WF]%UT9_=ATP,[)&>1S_D<1K3.R0O>T_FYA<,,$!&6,K&#(2>V_.[U M0WBE?1Z9-?&*S,A=O,C9Y+ 4&-XY7W%VPV^[YP1MQ2]17IMK16PF_LUTK:8' MQW ^W9?MPF7DQ %=?2 J<]IXUA/'_<*S4?A>T+./L*4<'K.@M/ASR.?G?P=S MSQNPSW0-U@VX9?M37H-;\"=F./%QOX $:+L73-'\>V(+ ?0B#LCE"\>) ),L MC)TQ[=G7Z0@(AOW?R ![IAMK@(Q'$D761>'ZL8T@QVSB1[W>$VOJB_IS M_,; 6=M6A*7S,LBWT9P"M\04?G+I*1M2)O0]S'H>ENQ4?>'3_ M4H_%: C+P@!5P0IC^*:T2D8B;*VESJR4F%-!JPYC-1R7,%H9WG$R"YM- XK M*#0/+BBT#B0GM',2 80(MI7]"TFA*Z3>.3:&>Q-2K]#C;/1]HR?CT,9$ MX55)%/E*%$JDJ"ASX)V_;[ S[>]HCMM(W)$>\7YG$D*@?H: M$2X>U8P4>3SQ@49%63TP XP.WX6E"*C5&*^" FX.G'\1RODL;VTX;Y(!_+ M M$=."9RMV+XA*"LW+AN8[0&TSQ6 M.3XX^R7PXU!439HS_F5=Z"9!6HAG( SS24&D92 8BOI;B7)5?'R\%%0&O);" M1T5#DF#YI;%/*K+()5<12HA1C0W;77!7<,$T2D+"S%C;GXFYL1*>[&F)U;'0 M,_^J)WK"T._BLQB^LQA//9+2,W'=?ID,[UA9>,5V@2I2V$\8#3)]" K4V>#*SD@_@V1UPQA%HP M91X=#K^'V6C>4!FQ$DL'3&B[_P>]5GD#>:F M&#BUR*6+2JL=8IF+Z2O""!?%@XMH\M@G7">_S7SP\S"-E#ZD$.^1PCZM*[!< MAV*]-WM66:@FG/R1"AEQ-%Y>< 0X'++9]4ZF7\FWGD>CL^\4YZ@EOL>9F#TM MLI'A@BUKN_S@[!$>)8U+'Z 1 5^8551! 8'_BO-I $LL,\Z;7"V@Y[ZR# M9\C\$X[==#!0GR>>P.6?+C1B^E%4"2SA>B8.K F:N)FOKS"MS\0-'--9Y\O$ MB(7$=T6HM-V# LV_VNP])-;E5X<=YK\QP8<_-=-#, MM^)3(,8NWHLWS+N>(S?I@T7R*8:7]IX_,;S(/FQA[ G3N;]:]68AYB8A5(,7 M[O3%T7!Q+;9BC4"\G*<3&V(]IB5QR 5I;XM#4*%VN83:Z=KZ6+L,=3)[>=7) M3!^'EU.WJU3I.9OS^O:&?SY+GD4%S@KFS3?!1Q3_F0W>WM[M9@C*@]S$W\(9Y]X4E;>[1W[!GU3K=[\/RJ5EW3 MC8-T=Z3F7R^^!QK 101FTV1L,,C:\65D6Y;##D.FM_;1XZ#X-"O:EJ:!P [[ MY/PJSZ2&=!M%=I2IE]7*5@?\OYU!>G""L+E33Z)$S&6OAZDVG+XKS8$.(_3& MJ0+CCW)$NI&P_T([FAR:BAP7Y7ZE9 AR^S\^_+!=HC.Z'XZPII7L!0&,A;OQ M&W6XW>]IR!@R2;HL"!Z6&DI_*TH#1;VQ!EC5)NQ9X-/09;EEBQQHSL%+/YXX M%RH-//7FH>Y;9;E:HUD@?.)6ZX]QA*KB9:6!G=Y2O&P;?#H%PD<84W[0"0=3 M65;-W03Z5:G6O%HBOU3+'Y![%I8+2Z(RLZ5:<^B5:[U3ERQBASCP/;GSJ4F^ M14)/;RO)=PM\FEKQW-DH%TW8D3L7>M+[<^="ES^8H[]D!QY2Z.(78@QQY9^N ME797"LCI'7FTNZ6"6R) O=FK3]N5C+L-/NWB24ZSM"2G-">=1!NC MEI%+XF/\V\-K]Z].^43>F[)IE@;4 MAB:/O">I3FJT,@*T9>0.4%C39C+9EI%,KE_UC@)BH2>]34"\*=5NEC7^4BU^ MG7DB!D>"F6*%=2V;*Y3@+A7P-[ P?1,+6RFXG\AE-A8ID;PX?^YI?$:<-T%T M/7UCQ]U2_(S6 5+\&NTL*7Y9]*UG>P24Y9Z]D4=O1%TXTN7LV)3U:+"^V>J? M1+K_MF1#+EPBHV[,=V;E%"O^Y0KR+MXV,>JXJ92W][?/Y//M]9?GSS?7C[?D MYN'QV\/C]?/=P[VDJ90W#_=/#U_N/ET_WWXB3\_PU]?;^^?AV*Y;^ M)$$>Y=9,++Z;LS]<.K&PG]]YIO,^-5OO@:VW7NT;GX&O5ZPVCE\.Y-EJ'7ZLZ5UAK(]W=B@P9 M2^*:S@NQ+J3!98I\WZT=O(Q.F@.+.'^.RQEIH@01ZGI?8=PP(+IW"6,)3Y4B\;Y+<)98I#=-QGB:;9[ :JS1 MB+2G^>/RP1UNTUNKI1Q_MZU:H]T]8-GD=*9G(8?E=M#X-..!'_*6S(3F[7/L M=V,D02)>\$DAT?$./)4DH(B[(NZ&T5#W4A%W1=Q/G;A7&&V3$_6G=J9%$CCQVW?C0*N+5SWDX4EG, F61=5JZ[*).,H*6Q:I9%CS02V.VK+;,>X*HUVJ?!N8I M/-A&@DZ$%RD2))L'X*Q;[ZU$?IJ(I@?TKA]@J@ EU3OJ4LJ(63@DK;5)56HP*,' M3PH3#J1!RRQ>3L9CQ][1B5:X<_[XY]5KZRIH0D*XZ)UZ5N%!VL"J(J(D*H0* M/:VCKJB$<($KFE4)5U>TFJC0KFNGA G5MU(^A$/FSQ5;B/TR->*R4"E7*0ED M33<,90&1$#*&EEFZ++7>JU!APR75>EF9E[JDZI*J2WI4,^5)84+US92?V-AG MIN@WP5W@=.3!DOZKLEZSW JC&!.9@LL6_UJ]<4K:L,*$#2),5O>:NJ''@$M# M.1=*']W72Y!K%EIQX(#" 7$W&E/;'\&"N)CCLR#T)V8X\=&J9@ZI_X)&-2X! MF7]/;-%"YX)WW6%X2$%9HP(/63\^);$]:DC@='\*+)O!HKQ@J D9& ML&07;90:64U,T-4%E1$LV44;=4%EL_,TZZU26'JP.\T+M;%]NDL"ZJ!=9U;A M*A:"L.GS_.^\ 1E0;+T>[AJT?X(:RYE^I(H/)=4ABT@IWZ6Z8:F=]*7!A@+N MIV&H"RH92+1Z\]@PJ"@/6:9>G!HS3ML M),"",,Z-+*=QH(""K8;6.G;!5JGT0H4;FW#C6%:*T\ -&8)3I*3>(L'=]=P+ M;\F:L7N*>Z7%N36I+A6JGB3+'!5"#Z-"Z2]EGT,UQZWDR,IV#;OCW)CTV<#S M6<2;24B_%Q\FL=9^)"%=7N=LT!N&[&:83*>M!/\31.-.NZ606%($K(#V*I_6 M>C?E@GM9'4]0$SDSC'9ZRY)20TX*-_1F0^&&!',H%;62(Q58*SE2@;62(Q58 M*SE2@;62(RMK_L5TNCW"RX]A)]O=5)9GBL2:Z$Q-^N#RK,-KPO(9LM5(Y<4YV9$*K)40E'4/U1QJCE-QTB;?]=]H8)MY^%OW]J')<3[I[7-)^Y(P$;%; MUWJRF^&4%U+=JG+=JF:]<2*U F6[$5+,H:PGE1RIP%K)D0JLE1QYT%9.4BIK MGVQG$C*KB%BHR@F62?N24+ $=4UZP5(5-U6WJERWJEDW.NI6E?56Y6W6E4^T M42.57'^R(Q58*SFRBJ$I:@XUQZ&-Q]GL%BE:4$L29?(G_P>S"(6ET!!SUO!N8HO47.4H!2 M$=22-6GK=FJM7M8:&,KP>L@YY$6.7JNFZ3VE-VR33W\),? ?_K;LUX^_PA]+ M)IM&&XY[[ 4VQO]?^LRAJ+I=O=E6.(R.>OXMD0Q]JH?W 0[*V]I4YW#$9 M%HF*T.3CKWU<7P3 Y>4M8US6EQ8^M2=&\GB"C2C9Z,*FOZ$>K!N+JYO_$U=J M6__X8.L:,SKM)FUW:;O9[W9Z/9/VS&:C9;28I='FOXWNA_BEX=3(-H;Y+_H^ MHW]=T %L[I(Z;_0]6#SMD>U>S(-V&2J;CC'U83W;(]#I[]D;>?1&U(5C6SJQ M[K8#,V8^M=4_B73_)<%T![RCAM'K9< [?9LMAA_C\^W][3/Y?'O]Y?GSS?7C M+;EY>/SV\'C]?/=PO_=5R6?)-P_W3P]?[CY=/]]^(K]=?[F^O[DE3Y]O;Y^? MUJYX1/T70.Z( BW'^!QR$UM-8'P/9W^X=&+9(-"=9SIE3I!G])3G^,%"'3H. MV&7\PU5L=+==_F7^TM7B$208 OGWQ./9S:]KXO9'LG7TY>AQG3]:$JO$LTZC M;FBMM8^UNK[CLT['V.G-38O5M7JOV\AAL8W6;D>P=;'IIEWC:-&3'"V^][:L M!&P0Y/(NH3/E 7R:2SN$3Y@I)+NS3W@'_(#8+H&O."!D!"M=4Q*$HPQRU(93 M$=.[F=?V(F&_69O[+Y+%>ADB=C:$;[Y- !-MU* M0H-#ZK3Y[S6=5^WZZ6E> BI(F4Q53;IHC3?[(BO0K"\9:VXFO@\(3&@0L'"/ M?/TR&(FE,S1+6;S[A@9#[HHW\0?V]\1^I0Z@2"&%6*4+DTX^LQ*'2:^I'UWK MM3NEMYXK[)(5N[K=1G'85:7:'LD'?&V:L/XP(#[H0T"_^X[JP9L:-]M:JSJ! M&)6"3*M=(&2J+_G=N:\@YWD^C[D@B' MS"?F@G%5B4]IY?Q&IZ<$* DAH]=ZO:Q)"O+9;5)3B[E8G&B*"QR/AW4D%PT/ M#7SV0NJLH27' #U?Q'(46T'<-8?>P 54]JDU6M(W1,IZX"42T2J!1)U:MUF6 MMK,P0IU5E=@4>+%ID/]YGMC6,,[ERTPU&N,HL;4X5H,$JU("-QA%(>[K6C>]&JYSW+U]DA1Y): MYJ9QZ3GH=<,K:%<.^J:J&NR8;=&K];N2-_+X\@>T'@AN]54EZPPV?H> M]O.G5L)5YB!IR5*%X,O=]6]W7^Z>[VZ?R/7])W+[OW_C,7.#60Q1G[EL8.\8T7R"+NAN2\4HR@F7\L<%2$P_ MOOG>@ 4!4 WTY '=> &ZX0U.E2F2$B]$I,$3C M="01&XWF+ CW4F).D-$9K:SHJ020JEO33K? D7P+SK%V4^FDQKMI#IPR566D M\@T5)RHC7'[^H6OHQI42$/..13=7'=A*0DR;=*]E3NU6,N)QS-S9RR'(9Z8J M=Q&G!()R#/CO'8M^0&9;B2(\[9K>,F0/0+D66QZFL"/*)#>!WTW K,G:H2[P^K(:'8BG;5EJ[>.;^+DKR M. Y2DJJ<:!BDB?(R/2>BO66$2Y&L_R1WO*1"N$UFR7S*;_9#MZ9=D]) M%W)"IJ,7")D"_&9'=X\IMU@U/!J&46NTE$M#8=%^6*35.EI385'%A<8;;S2R MYUJXGHL(X7L.#'N9)FP$\!,O6!^^ MIF3;92M8KMT<L" M5&.3CNV0[M9NZ025K%9--[*65%+J[S$@TZSU] (A4WT9XWJNG9+H+HWEV4"D M9VY@OS+B>(%RWJ<\RS.]TSM7DH=D,.GJA<"D^G+'(PLI#RAFU'=AR8P\I671/%$%B7C;>Q$:];TP]$9)?;'WN]AR ML-O,'3,/>"H2DKF&7C,TZ9GEP4%1L$*B;J*ZB2LY0[U:NR.]Q"'-3>0BR2\A MYAO&O'(J-7S\M8\/Y_EH3L_B@XJ.M-&&,Q][ 8_LO/290T/[E5V]V58XC,Y[ M_JWH^+39*[0/)S4)U[\R=T@F0[/=AS3+6S[:K"\M?&I/M.1NJNURT#?ZPLA, MC8NDH;D_<:6V]8\/MJXQH]-NTG:7MIO];J?7,VG/;#9:1HM9&FW^NZ%_B%\: M^O'JQS#_1=]G]*\+.H#-75+GC;X'BZ<]LMV+>= N0V4[VJ0XK&=[!"+G/7LC MC]Z(NG!L2R?6W79@QNPBK_Y)I/LO":8[X!TUC%XO ][IV\@P/\;GV_O;9_+Y M]OK+\^>;Z\=;U:Q]1_P70/*)%RT[D0VYG*Q_DNSG[PZ43RPZ9 M=9[IO#DKF%%6SGY@H0X=!^PR_N$J;J=EN_S+_*6KQ2-HC5=8#_^>>#RC 75- MT(%(+XZ^'#VN\T=+[%0\ZQCU=FO]8ZVN[_1,KS>,SHYOKE^-KM5[W<;!%ZO5 M&ZU6/HM--^T6BT:&]+RM0WLK0Q-$9BZRQ1@]]QLA7&#<, MR*UK,2M+^IXDQW9(X3W=L7VEOCDDH$SOQ9&Y7CS M\/+M[".HGKDHVXXE- 7UM+;L=J!,9URP[S)??V75;D<9+DC;4 W<"G+-'@W& MU]9_)D%48C#TB,],SS5MK"XWY:/X>_R728,A&?O>JVUAIXQWXHV93[$@(:%F M:+]RIZZJ&I7FU%75*%4U:GU3B3'<0IOWG>$A$G2$#?#^2W=N@G>"R8J&H9I+ M2 D7K?P%&Z6F'2L-:0C[/F9NP,A9U-LJC2'IQ&*_UR4L:BJ'5"Z09"UW(U]D MO,3$XPD3SR_Z-& 6+W0#5$,((1$%4;)'2AY78)4$!9;U8"E_WTR)BG,6%5264TD@XAAR%AV*PX2 M=CUW"Q3E&UE]@4LT >*]Q*(2ID@.)^Y"/S$Z& !UA!^!G**+&$; :86^W9\@ M 0W0G\SLUZ7P5B4%K!?.E-M*1K"HNJ>C'3:9=( MG"P_^G3UED*>2L?B\ *L9DS)P0MQ5O.85.C-3(6<^* J MHCW;&Z#0 Z).^#YM6CI&';!H44<^CK3.EMU5M?2D@TFG47J#5 DH1W\2P(" M_\LG__%L6 3&ZDQ\!HP[9&B@8A.4$F>29D<&CJ^26(QE8 M9+2OR.EF,@]RS$<((<_$QO*@N07"!11?..$8TS"7B[IT0?<-'"4_E# M*HYB8%062#2"1LKM$!6Q!BZZY M/8G%"1H@BO3J*+"L!XNR"^4J8,Q[VTQO-,*.5]C:5\D8:1F:K@H'2@>3II39 M\_+I4,J9-L.:3PN]J,;4MDCH$3@#$U[U/<=!H]0T!EN)56E=;;UB0GL53#8E MV&2HK*HDJIVUL/F6*PL5&WU&$M>(NO0%*[-1GV'-6>8K 4M5@RP];,[T#'12 M5A&K*6$]R.3C?L;*]L($%)=Z1%,0@Z\/D;#,ZCI.4_''BYEQ."S@78CA73@? MY@NS.EXRK7?5IP$O'SG"&MBB:B00DLER>)0G7548;#$%D@T@*;^$5H[DE:00\:(%I[71_\L) '*@\+J\AYK1S%!Z M+>O>2V1 JP8\VUGB((X%S0-)-?(),TBH;-?T&2AWY,QBXJ?S:1-D+%O ?\"* MD*_4D:%B0F9D+P J']TJ2T;4S3KB1&A(^NS% M=ET4MM#(!?-[JM!DVO)-M6ZWH8+*)81,HZ;I6=MQRA<&)9^JMI&2,*PSN1<- MV<(F\V6-NU/V[A22"9/JEE3PEO1ZZI947$I_FHS' MPN=,'6+9@>EXP<27I#C&'%@; #C+FV#)QC5PE8]>R%$ZHS2'J-J^3#=]%T7A M\F"1N;X,8QNN*4QC3>-TBY!XI6/7R8>8F5W+PY'7V:\RU!>4SSVKT$I2M.IE M"&!7/N9,9-ST1HR$]#N)8XMS*ZBZMQ%-CB-+?[N2]B7C[K',/]%WV?TKPLZ@,U=4N>-O@>+ISVRW8MYT"Y#9=,QICZL M9WO$ G+/WLBC-Z(N'-O2B76W'9@QTQ97_R32_9<$TQWPCAI&KY5R6?)3_=_O/K[?TS>;R% MA3[?W?]S[3I'U'\!E([HSK+D>,BE;S43\96?_>'2B66'S#I/N#]1FY*85G); M#BS'H>. 7<8_7,5QWK;+Y^=1IUK=U>^UBKZSL^Z^F[O;EIL3I,VVWDL-A&JY7/8E-/FR#VE2X'(8/= M<^O0WLK0!#%5W/H\Y;IE_I5L,GX>^HP)EO45!@\#\?.M:Z7JQ*J D@=0OE+? M')*&7I,% BGUK$-F:TU/BD]SR>W09AI%Y1.R*#_ <%7XBH-5L%94E_V0+76) M?!EQR]",=AIST-8]GL!!M7*_?U*DV^7@.CZTW#H-3/?&S*>\XXO/7ID[B1S' M1"*GY]: /E.5CK'<;YG>,1 DFI2C U.F8Z,L+D>]2<.#3W_G=Q0GRD?]NDX M&_5:P]!*7PQ&89>LV*7W=LS:R@^[*L!@-KB0I&0PG[V ATJ1!R&?8NEE3"!X M8OZK;1:?UUV6C)9F36MV5:Z1G) Q"LPUJBREDU>47F,P]H#,297V))_PDW2&[R^]02K_G/ZP>O0TL' =FSX<8_$ MORT\LZA#+=:[H([I5)PP9;.1'<()H[('2ID]T"JP_:E"K6JCEG3]CBO 6N0U M2A[1_9)6;JI0\6?5.T5>V!BR0:4"=$Y>$?K0SI<]I9L3LB]GV[&,]F5==N-R MIB.67.Y7-Z-$-Z.M;D;A3/K(;I<HI2N0OD#GQ1:)C4FZ5LMF^5&[+R68?-'?M&".1J4[AEJ2XU6K+ MAEL58"[R&AQ57DN>Y]CNJ*P6&>'2T3JRP:4"5$Y>$5KEM!1E/"Y]V+Y>T]N& M[/;C L/VU>4X\<(V1=5-! TVO5B+ 1'V^%/"A52HD*WGC4&MX*H4 '2+:]Y2F4WY'F.>G9: M?AB?EE076*$"HD*GWE*H4 %:+J\8?N0,CG)+7&M*L.OULD1LRT<6DH]42?MI M<<^H2V_0KB#N2$C%0@* M'UG9Q+X;*JR_[/N8N98=3OQ]BB9*%K)QY#DJ@+9E\UZH_+23S2%J2%>S2*%6 M15#+*,9](P'#.$EGBLI.R]4;JGHN*;B<#)635X"6,SM-='5/BE4_V0R=O8]$ M0N^%@B2:Q;J]IW4[>M('VT@\^TKG5@BWX*K-U*!H/"1"@2%CU0@ M*'RD D'A(Q4("A^Y PB.^,HO(04A%OZV[->/O_(_#B"(=[<)X@8*XF0J@\N MU+;^\<'6-69TVDW:[M)VL]_M]'HF[9G-1LMH,4NCS7\W.A_BEX;3^. QS'_1 M]QG]ZX(.8'.7U'FC[\'B:8]L]V(>M,M0V72,J0_KV1ZQ@-RS-_+HC:@+Q[83 M<@HM\.'<3#3_'Y]O[VF7R^O?[R_/GF^O&6W#P\?GMXO'Z^ M>[C?^Z;LNF(^S25ZT&PSQ1ZN07M':D(=\C09CQTV@D7!/^X]]^*?U]??"!!7 MT_$"#%!:NZ?(!G"!)JC+=KW30LH6_8[3D/B7.6U>U]/!BW*3ADYX2RS]BCPR MTW--WK.6^QF] 5RMD-RYIC=BY/J5V@Y_)?3(,W/AR6=&G7!H4I^1&\\?>\)! M"3^/1O#7TQ >##W'8GZ [TP+C*R;-.&]M6R.+'&FSGT&1,2Q%<8/ S$S[>N MQ:S<\\,44)*!\I7ZYI T])HL$"C 9]7=*A4E>U'./B&+ BYNNP2^XJ!T4"/L MN\G&(1DS4 R091,Z\B9N&)RG..$L,=%I?2TR8IVA&>TT<0U;]W@"!]4J<^YL M>I_YAOBE93&6TP/^;QMXAQM>7O16Y;_C.W)1?K>%_$Y3*P6F$.Z#).'^@#%R MV]Y;>TEV#BH0HK><0069-[W54WW\W78TZ4M29SWF]($!T^-6=T3=D?6[;6IE M*2)3T!VI@-R0'-,K7\;"%Q:HHL&J H@:J4!0F9&'5/*:,A+M1_;*W DC ]\; MP0[=T*=F2$+FCVR7ZV_ES#/+4Q);TU-0;QPSGRD7_:"*<.$^3N-*-MA4@-1M MR#7KUEO;#%K->H)+\_CT[VXTIK:/SGZ>7>NS(/0G9CCQ84O$'%+_A04U_HB: M?T]L$7)TP:.4&)Y3$!ZD1/4AU.D$]_;6,)GM@47:D,S9FHP2Z&Q]H3:&8[HDH [*H:"@ M<\/YC Q:;/%WWH ,*(9RAG99FZ<<7[;0CUEO24E\:XF\1P'380V1E&"(AH0>S1&UPD(8+3OO3)B MAVP4$*63IE2 N@V)%" %$@!)6]7G.Z9:6C#5V](;W%T3^GNHZ-[#%!0[DD FE$2L MW"JE1:J\HTN.+UY^LK%PCT48]5U8:##+*2U-*Y42\$#9V5RWKNDEX7,E$O<4 M-AH!6/UI4L\J]RP 432*@5( $EDW#]TM?4/IIJG5H%Y+(C5( 47(QEE3.)1^6F8G MQ)84#NNPP7:JUO2IU9JN=Z5/V3B5@NRG=T-*<#T:I:_%?HJL&4K2SRTY]BO+B?I7VE:ZAOIW:JV>].J;LIL?A?JW:IK>.WE<*!WU MEV_!U1NI0%#X2 6"PD=R$/P28@TT^-NR7S_^"G\L&1(;;2#[8T\D]5SRI!X0 MV:[>;"L<1B1__BU!DB^UV2NT'WCHL5O[RDHW[XA+?ORUC^N+&,GR\I9Y0]:7 M%CZU)V?UFO]OI]4S: M,YN-EM%BED:;_VYJ'^*7AE/3[QCFO^C[C/YU00>PN4OJO-'W8/&T1[9[,0_: M9:AL.L;4A[6U8<]R4_65 S.6^_7,_TFD^R\)ICO@74+OH[T$07Z*S[?WM\_D M\^WUE^?/-]>/M^3FX?';P^/U\]W#_=XW9=<5\VDN[1 ^8:;8PS6(ATA-J$.> M)N.QPS ;$?YQ[[D7_[R^_@:Z9& Z7C#QYX+.E_<4"9D7J"%?MNL=U(KCWW$: M$O\RI\WK>CIX\:*4/QB$9^#J5^010^PQI)Y'V <8W(6Q^7>BCN5UZA;V-Z+( MY=-,9_:QK@H9&,DWT MY>AQG3]:TH;$LTZCWNPVUC[6ZOJ.SYJ]YDYO;EJLKM5[N2RVT6KEL]C4TY9' M9%LO-6=P.VX=VEL9FF#K$+<^3]OBLJ20;.QX'OJ,">'@*PP>!N+G6]=B5@KC MH0)*'D#Y2GUS2!IZ318(%. 5[6X5>-:$(G]"%@4,VG8)?,5!QI_&#)XEKB%M M^(R,N&5H1CN-5V#K'D_@H%JYWS\IG&2;,FZU;3ZR(V?<)L/J?DUU^HU2_:%* MUTL7"'W\\R\R$/KXN^UH98D-R"$..I?V*>J.5.V.-#7IO>G%WI$*R W)+FCY M>H )IF%6\+Q]=UTNRZW.5RAO@6T?=<:ZHF<[+!1&]+!)/2 MD3OY%ER]D0=M/M^3F^,4'3"\1\:K)!2MMVO5A4-G9>[&@XX!RS*!L[UK&WJE M5YZ,P!X%E(3T.V'?Q\P-.H,FWX.J-/*A( M+B5/>0B'S$>3SX4W9NBQY!8?Y#,U;,9=M)Q>%F+6/&J/G,)%[K* Q3AJ9;I* MLIE*R,W"@JVDYLR&[ S5-I74?(+.A0J0L])941^6!+6B9;1*V-_TFM$[M$%5 MV50+-I$WL_:&4#;54Y,-\^D3>X*"25,_:B,6)3#FVB96"8X5M/5]8F.?F?:L M-Q@=>;"D_Y:X'W8AKJ3>D5I0%"X%E@V$7<-IDL4 HD MW)>>@2G+N60ZY8+U''4YJG4Y&NIR%,ZLE615HI$*!(6/5" H?.1!NNNF-1\<:8[# M]*TMP1*E1:?JJ:MH+YUE^/DBZC$7G]#>3@B,5" H?646UI(1S2(L8^RH8I]@U@5#X'_D)@SC< MHVDSTSER"Z<"'?JHMO9&7:^TV'3D\_Q)85V*4^K4JZUZ2HATTO(^)10IH>CD MA:*E\*&ML@TY6WY#=$%-TW-.0O9S_ ,W]+KTK6(.8RZ2B@LIW..QNO43,55* MA7NE8W3R+;AZ(Q4("A^I0%#X2 Z"7T(TQ<'?EOWZ\5?^AZ"I?7P8D=?XV9+6 MUF@#F1Y[(H_^DN?1VZ_L*F[LSIN^S[W5]\+0&UUJLU=H/_"<2;C^E95>O1_2 M+&^94V5]:>%3>W(RKHIL9-2-+FSZ&WUA1.\LKF[^3URI;?WC@ZUKS.BTF[3= MI>UFO]OI]4S:,YN-EM%BED:;_VXV/L0O#:=Z]ACFO^C[C/YU00>PN4OJO-'W M8/&T1[9[,0_:9:AL.L;4A_5LCT"3N6=OY-$;41>.;4O+Y)4#,V:2S>J?1+K_ MDF"Z ]Y1P^CU#BA!\5-\OKV_?2:?;Z^_/'^^N7Z\)3'J^?[Q[N][XI MNZZ83Y/4A3UY#]<@K"(UH0YYFHS'#L,"(/"/>\^]^.?U]3<"M,]TO&#BSWD' MEO<4B;P7:"FX;-<[+:1LT>\X#8E_F=/FT0"6!E[<;_)#@_"*7OH5><3D5DQF MY1Z3 &T'Z&JYH<&0?/.]5]MB%NF_DUF]T&L3B#3/?47_2]D/Y'>?,;';WQWO MC>?[3FTDB\_6[E384"XB[K1L.LKS3B93MK,_7#H!E&;6^;YKYKQ]QGYYN":L MW:'C@%W&/US%LH'M\L7PEZX6O]!:-9?Q[XG',T91UP2SB 2[Z,O1XSI_M*2$ MBF>=9EWO=-8^UNKZVF>;IM6U>J_;V&G:S<\:K58^BTT];7DDS/5"_E;S3V]E M:()]1V#[,GH*S#R,#+BU=E/ZT*],IUQP62%U.:IS.;IZ2UV-PAGPT4.&Y"OD^6T":@D-&+?G ;L& M)AV^<^,6^WMBC]' N5:V*F7(Q+J2CUU-HIJ/)Q;&LK8,9X:.O2KWK3KZ S>G M0@O=9L*R5!*0GJS,N<#C MS()FO94]@6.UKMQ!B_ZDE5./MD1IT:1Z8MO4[#L)&/:$B-M"[&7RK2I;DIWY MG#6R=$&0KPB[PBM)\4KORH17%6 /\ID:4[*'@>U2U]R1/:AZ6 5?XYK1++7) M5&&6I)C5;G8EPBMI&<1^:F:2] 1HWNB4I:R *DU03N9_L) @1:95>$_AW$%) M'15!YQ($Y)RNJ%-F4^F:_KDL"'[^H=5=@;[$TI*2N'8J!E4XKGVC[QC&%9"! MYZ_M5+^N2[UH8N_8B\V=^2\#%H8B!79]*M .VE$R#)[/[S&3V*[ "Y!PFO..#GDY"YH]LEW.#G>A^R3H?MYJ: M;*V/54=JKCUU#=VXD@TV%2!69;$I3LMON+L:%[,(17M$3DIBX]!K>JLL=;'E M"+8]H$Q=?O3IMLIB[U7AJ)4VGN65LU8R 2A;SIH22H\#DRPY:TH8K: P.M@M M>6V1=47%T);CWD\H>^>0YR&A,-7KE$P2WPL"DCO=U:4[C4O75I>N:J+$2E'Q MI;!(53C\P(7#NXNKV[%P>/O#1U4X7)[_5.'P$A0.7[LG?N?Z/4OO#1IMK3OH M-MN&UM-[3:8UM4;+,MJ-?O??1I=7ZU_/_K*6S=:SU!%O;JHC_C )'<_[B]<3 MOQ.M6Z]3MVZ]$:U;G^9;M\([\9Q3O6S=Y GO5Z* ]\<2U>3NU37.8I(?E[$> M]98]+#W+H\AWMVYHN\VZ^5FSU\QEK>G@OV_-Z'PQH5HEJW__%UDI0GP:Q:5K MA'TW&>A/8^:+IN"$CD!-"U.5G9:2&NUW6=9JG E*IXPUHK^L6F)WW>4)G-9G M^#G+K<\6[]9+H L+=6WT[JJ\44S&FBWD19I:%,!DD"9.RDH'T(V6O1G9( M%BEY-;+C;]6HM37I>H?A[3(WME[H21@>^-LJ4PR8*=.:IG^4=@YBF))0-U=O'!X3#G>C,;5]]$#SF/E\*P(<8%>M M>K>58F,)43ZHXEPTZGJ"_[)/ X8S8,CVDN]46OI^#(DFM^H QZP-"^]XK(W;(1B?M)U-57Q,3P+%6*2@GE.+5[G,(F2IQ"2D&W'$H8DZ+6F(7V\3DX%6W*Q MQZC+4:7+T5:78UXPB%=QN&XB,C/&8RAS*>;(JPEG@4L\:#GMDD2*?[(Q0=PB MC/HN["&898TH6?+ G2Y*P!1E9WU&K]YKEH3UE4CZ4^AJ>$VE0@&K;]:- M#/*7TFN/!)1FAG8B*E^F2B-/L>;:-%[3.DV7NJH8=3(5H_1VO2%]-PI53DU= MCD(N1[?>5I?C8.&9:45G61BC)*6;\@K/+'")2JXO?*0"0>$C3U&U^I/_ U0J M"DO!3DY!+YG5:KD_8FY]=8T\N[48-:2 MB%<2:1@*%RJ "\D"=7>#/%U!L3G#EHXX-)$MZZV5E^1BOUM[ >HBON6<$/(\ M9&1@OV";-V"[WIM+?#:&?V#$5#C$5A(CV/3[_P2$!:$]HB$,]_SD0"HR=B8! M?XO"$^J0=T91$[BP\#5X9>*$ 7_=/D985IUO+MH *"*P0-<+R0MS0=QPG'=< M"3-I$,XOYU ?)WV8>A*@;W+VZ3YS; ;R33BD(3XPJ3M;!)Q;$+DRR9L=#DDP M&0QLT^:'9)H3GYKO)+!=$^0CK!K@#19>P;X?B&!1N"\J752 $,#&YF%)QK[W M:ENP)AO! 8-=$Y I[D]7)PM$< ?E8*$-:DI\WMK@/JH6N//\= MJ(7NH85\T8/U@&U?TWU1]>Q-X OM>@>K(L6_XT0K_N7FYKZ=MFGU.OV>V6_T MFA;5^_U^J]_LZ9II-'N=-OVWT= ^?#P@E+,U]VT5WMSW]K>[YT_7JF^OZMN[ M_\A->UAZIOKVJKZ]JF_O@?:TEC^G[]M;)5?%"?6;5=UYI>G.6Y[:GJH_KXJ9 MVXHD)Q0SI_KSJLNA+H?JSRM9&[2C'?9IU(\Z8.RHU'-4OT_*.OEU71YNI=&Z MTI%7:^P7/?U8'5)4-%QJF+2+@8D*"B]\9/4K/43>MY!^)^S[F+E!M9-I3[%@ M0"]+AR=5Q.$H,-%K6A:N(E]A0JE)FI".3X*@G:) UE5"LGPPR=)76PG)51I9 M?2'Y(1PR'XTP%]Z8H=>0VV!0<*YA%\%*,Y@3E,[TEJ9*>DL(%T,K$"Z*T10^ M4M54+Z*F^@%VU:IW6RDVEI!0A [/BT9=3X@NZM. X0P\CU(5@*^D5J$7I%4H MF*R'24M*1:\"6L8G3/LV198,)\9TY,&2_JL:!U50ECWK=I157C:8] HJ=UU] MF_QI-T8[03%!K[4S6U&4 '<"D%%VE,)'5B#<=TNI^*74[^*/_.@R\[;W3BA1 M(=N.)4Q4:-::7>FS>#*=TV3*'K0_A0%+O&0GA]5RD*ZZU"@$EQ5:5YVF;T492GD\[DI=)85 MG4M02$(^=Z5\]F/DN;,(;U_X+*O-0?>L=U,YDI.T+QE)CEYKG52+%H7/U<9G MH]8X*7Q62NT^2BVA\#_R$Y82=T^/9U(/8"E2:2L_(V?+;XBN#E4J;GYBT9EK!&&MWI.= MV!Q&#):BY("'NT]=QO M\]G:<[;3MN>\H<&0?!-\Q"+]=_(P-4Y#@4. ^S_?@_-UG3+SYN^.] M<8ZYTIYS<4R6-IU%G_1I]?/LUMN&L?;Q[KTG.YW=9JU2G\Q.JED/URD?*%R:#\8J*$,9Z37V;.%3J37W*P$&][+S4: M52D.*?VF)33F-FIM^>-\LQZTY %YZI:4[98T:UI/W9+#AOG)5]#KV\0WAS1@ MW%X [!68:OC.%7WV]\0>HP%%Q1>E+#O7R5+E5+ZTI$K")%,_B_+EUAR?+7!S M'Q?&!TXZ=4WU9C[EWLR]\HO:E9"SU>60[G(T:D;Y)6Q5\NADZ]BHK0^,QD0%(O3RQU[3"GG)YQFJZGZ7RNX%.R8 M3I#5A&1F].I&*R]);$NU#C>S#:I0864/IYXD"G&C9I2F+%PI_,"GACYMA3[5 MMK2H0$05B%AEF)Q*(&*6 @ 'E.@&B6&)^1C$DI:RLT',R-$@IH+%JA,L9I2H M4'@I)&AU.:IT.;KJ$/75'*#F7:J(K>PEM,M'Y<@@.Y41K&Y MO7]!A/-%EE(4ZI@187UT1+R(4N]ILC1#, '6=B 6S@N'F1 M1,\/*>QA$ADRN$8B!B&&XV7COX+G%A9:&D=6#]*? *19P%_SR7\\&R9YA2.; M<"@#C!G'1'B&2T>@"BS@F(6H8#HT".R!#?/28+;4 );NCS66MSFQ(+"2;F$+]\9B]M$2@)?2= GGWO#89' MU^G,AG&6#=??[D]$P:HQM?D+KN=RKY_G.'SZ>/?U!4Y;_0CMHI>AMJ:V-K>U ME?*@2S*F*@%ZX!*@^A)?GO^S[UGO\-7'(7 MQ^51$ D'8 ! !T:&,M,C R-C T,S N:'1M[1UI<^)&]GM^12_9W?%4 M64(2XA"V23D,DZ$R/@J8S62_I!JI,5TC)$5J;-A?O^^U)$[9"((-GGB^C*&O M=_7K=W0_SG^:C%QRS\*(^][%.UW5WA'FV;[#O;N+=Y?=9KO][J?&#^?_4)2O M/W<^DP^^/1XQ3Y!FR*A@#GG@8DC$D)'?_/ ;OZ?DUJ5BX(EN*B8S^TJ?.:9B6TZY9%7*E7Z_=NK4J[K&^K9=LLHETRR9FM4WJS4Z MJ#F4FH.!KLEUAP)P!KR]Z*(P%"*H%XL/#P_J0TGUP[NB;EE6<8)]"G&G.I\( M)6+V4F?XK-[Y]T7NN=QC2)NB"*D7(>I4 #&+AJ:7%:VFE/3Y/$M33/JA*U>$ MGJ6%B1:6S>[_U)J&IFB&HAOI)).(9R%I:)I>_'KUN6L/V8@JW(L$]6R6CG+8 M?)1<-D47&G 1,^W()O8PNR>V+'4=1\H=I<&L]X!&?0E+TK#4&:?BCU%+0VHM M XRMS@K,2>=*,6Y,NP+MOCTQ,S;W:32?>:W_DIQ@J^Q:=RELF0+SE"_=0N-\ MR*C3.!\Q00D.5=B?8WY_46CZGH#MH_2F :Q@QY\N"H)-1%&*7+'QPP\_G LN M7-800UO!3:.9)>V\&']W7HQG[OO.M''N\'L2B:G++@H.CP*73NN>[S%8GT_J MV)&%\9_<<9@G_X3V:]C"(;?CY2>BPP87!5L!,?7H"&=BO-[R8+EI$X +J=OV M'#;YE4T+A#L7A8$";&IH^*^JE?3:>7%IUBT6N01-XJ V^>C2NP*)Q?BB ')? M'_ )*CP$6^R^^&(4*\R )U$CG '[G2KNDG M[N#G 6 M_<5EG5A<.(V*<&;%!Q=*!=]DL/V!NG,^)CGL1MQ3A@RMRKIIJ-5R(,X>N".& M=5W3_E58ZHH *=3E=U[=!@JQ$)JC@,)1T0]1F<=_KZV0-4S0OLO2#GT_!'P4 MVW==&D2LGOYQEA[$L96FR$%G(QK> 86W*9NLHA<+VZ>HZ)J M,3H"Z":<=.6D686FXOKW5DVUM.PF3=7E]T4Y7Y@V)H0L!:(@QP F2)2+0JFP M@FP"OAX($ODN=\B/(I@! M!-N1D#^LIZ ,0:+!"1MR=UM_U8%M'Y)H]D(X_HMZ[TPBD M?Q#WB?C_6%VOP0+RXT-,TBI,(84@(;%N(#N_7+=[K0^DV[OLM;I;"> + ]IM M-;]TVKUVJTLNKS^0UM?FI\OK7UJD>7-UU>YVVS?7AX'>R 7];S0:@M@)WSLE M']2F^N\?]8IV9FAETSH.L,U,L&,P_UC^ET>Z]:;SA7)[P2D M$878(XI-?=#Y->7753N?' <5\DD?[)Q.Z[I'.JW;FT[O. 0N&]+;<1B-J2>( M\$F7V1A'('J)^"'1RR?.>^(/CAEZ##T!U..0"PX3I@8!_BO M;K?GHS^:@TCH#@O\4-1C?+;?_;?2D&S%YN5R*,"!;Q1PC,00ARD.G2I31D.% M>;/(0*%Q&83)CB$&&BYJ'B2DA$0B!)S"-Z MY=C9>5&'SK)44R]OZ\_IF_VYMZGR3[6][[OFOAYSMP2]3?V-8((C%I6ORP;K M,NP'A0U>>3*C@L/KAFJ4%[Z3:;_TR\.J-6T7/=_V;#^$ UCFUF0$K^F//1%. MF[ZS;*1@>A#C:((%H7^/\\RM$[/0N&;WU*%/&R1%X>R):S%WGI.\:]I7R]"^ M.^$3BT:V'!ZYM'SD+H/.?9#LA//E0D-7JH95>I3S;SQ_W3SOT4D[24#84DLL M"T"ET+#*BE$N5S5+?U((=M?;+T&]C>%"2;P3J2+18%Q2G.]?@;2O(OBZA3TG MNS#?R"/,4Q'47226W3=V;6;7LR/T",?:G2YIC0+7G[)09CV6E4\F!S.2+=DN M4?7@1MI.SOBEXX0LBI+_/L-\>JI^JW#^FH:FDP\47+F(W-+PVP.=YH\KOUYR M-.'/F[#G/\S,T!K&ZI ,J^B?;A&L7UI#JON;\!8L7BZO8L4+685&[^OJ(MO& M!9<6NO7!M';_RX/8[DYR!%JA42T;9?,XV)DOHW:28(2'9! "U7A 7<(FS!X+ M?H]G)^QE%IT2:'+'J)3(_W@ A'+8XR' %XVHY0P@Y>-0J-FE13#T+17)3GSH.._?ZP9>O4L(H*Y+$ 4 MB2=Q7!0;"B3=(#DIOQ*!MQ%VO,(&"&8YS 'DVH1'XU=03WFCR-W2B(XJZ/!5(Y, M!OA]X$)\A/OQE LAUS',$Q+J3=.V@>_"XC@.@PT<#;BHOHF&"X'*PX=!:^72 MMF%04ZV6*WL)$EHE53/-/$'"O4;1J"[%(O4G9TS_/K MR]]"+D!DT2<8>XD]&:W'N/J^[_;!C/ %[(*93BWA3K:JIGGV_)&.9XX+9-,Q MH0Z OT@>$BRDSCMCV$.F44[VZTI>&M/1)WJ5-#]VB%'25.B88:;_O42NZ\M; MC8#6%:A5!"*OO)G?N[S-24-&"6W6A4TW*9@S"_*V=/EA)FTF:#79\V\O<+!0](I-@+--JH\73348R3_OM\8ACW?1/$ M94%L1]&8A3N(8^5-'%?%L<04\\3.)XY)WSSQLOUA;N6[>CLW'6)7@(7@3 19 M5_7D[DM< T!QHR>0V/V988+7<"&BI*OFEO<%'O^^9EA[<2J.%:B::3R3IW-4 MD?$>OHV,[\_90V+C&YLM-&#.2Q9'3X20(IPR,="=COJ^>Q)MD\WY3LAPG=Q: MDZ+ 4N4OJ0+J\F'(X>NY3MW&%%EXY;+^!.;PY-EXLFRV4HPE_RP^@Z:ZT9?[ M:V9V5 N-^*TB0.W;WT[)/S55*Y. AN2>NN.,![K[DL&_&0>2'1UOYAGY:[#5 M/S7?B+QG,4_MQ,4[O;H%^N3W;NM%[VX<(\5*>12#H14:%;56+?^+Q(]9B7S- M2IPQ(X96>OH&S"L_F_9-X\RM;^ARZ[]1=L_CG'#49^XFRL![OB]58F<8%JO>B;CW&EG+M\)!/A. )^6Q, MC+FR'G&ED\:>^WS@PKQJSAS805*)K93 O\0$;B8$3F%^Z8C53I=+4B1B'!(4 M<@:KC,U)HA=FR<;WI(>4E_;@B6V)B?[,/<[7LL=#V,',93;6ZO)\&3D:1TSV M E8G.6HL(L5E-"DNZ( K9*)#4MO%F M/';&NDP.#9THSDX[CX6M2B=T%K9:W/#J\IV @^R+F9P>F5RNE+P(_)AK]9"Y M%.\//5H$(Y%D;3Z$]L&N'XO'AQP^/'B\!3#6:USD\IDV%\#8MCA*=58<91C. M+;@[IO1#1K\I= !\JU/W@4XC7'>["BJ/E]=8$TQ4^PHP,*2VJ$?C$7![>HAP M MR[R!,S!)+\%)1C[.#KFF#XW+7IPY')O M5C52VGU4VOC@'S!\U1N1/L/#?# ./1X-5\YP% &"W$=RI9??3@G>2S2TL^U( M*0?I9Z0WE+?FYD!%0[ @I]<"P(#E-:L"B,X1&DC)?;Y'KP E'I*<;-7P M.<5@-0OB-]82^3[:: '>%\9K@TP@KF")P<+)&VQ[&8)H;(.=E@"QT1LZ*I&\ M\78H&?/7BD94DJH1Y+&"$:>DQSR@^B=&73&T:NIRERX)>:(0 M%F5]7;">KL.5L\R;EE7G+_O%] MMC9)C^YK?QO]N'L"Z#"%![)Q_\ B.^0!6F*;D['&]KEMC1P/][/O1J+!EOW$ M>8<\OL16RXOK7RU;L^L-@R<%\*F3<3!X#A[$H#G,3ER"NO3[L!> 0S-M6!9O MV;-#PD962MN72CJ;6)8._I&'1;!#=2A&\NXM.!&=F1,A/1KP>U:=)II5R&;# M-GQ=.TW7S"R:!#I)I>UJ-8SW!ME^C[:]F] MP^;7-F55M@ZZ[5^N+WM?.JWM:B4<.OBY6($Y3M__.>9A$AW( M%[\^E9TZRWE_9^Q.B4W'F*M?C/K!,GUP+8%3\8F.13S[;$C= 0;Z<")I+"0= M, 0X]F",G(Z.Q= / 3GGL3C@7@CW7=3[!'DJ5;9^Z%Y3=:.V%T_85"O:?EZ2 MF"75JCP=OLSI4^^W[N61&SV9]8!7Z_\NF,LKYY!>/EQ9TF M-Y@SJK]XTJFZ0ZGR5Q/SSB;TS]/ZJXO>9V-2C(JDHY)N\Z;7(YW+JV[K]UT> M NQGQ^XSAG(0:G:2FWY=&[0SZ=!1Q*:'(^=KH%CRJ.(_W&8$HS/RM\].\3*% M",%XP5\,R^T9'X^K4XQ_RE+^_&7C_U!+ P04 " #@-9Y[OKO$XNIAU.N?O,'[X<'N#KB1M%B ,NE1 #!1HR4R% M3 7HAU2/[(F@;YR84JH%QC-/NY3ULV+SRJ!>TAL&6,BJ29)FE)0TP656%'B4 M#3* MC[WH2D\TK6!!D&U-Z,E*3Z/*F'H2Q\OELKOL=Z6:Q[TD2>.'SS??/33:8#D3 MCWOH5:YXP/=CE\Z)A@ W%=U#&Q!@K2#<5%TJ%[%K.!GTK:?$&,7RQL"U=>8* M2M)P,XT:\:LAG)4,"FL[!V?L'F G;8B:@_E"%J!K0N%M^\XZ"#E#V**6RB!Q MQ"Z)SGU_C<9S0FI''41H;>"-I,3X[\*AM85[.TYR8N!&APAVD>Y*%U'\QPJ. M769"&R(HG"[C),6]X<##+H33'NZG?UW#]J3;U1!X[6OP8AIH=RZ?X@+86T[B M$.X6;;S?$X$5K=IL^H+WJQ/;$B&D\0HNLHG5-1.E7 =LR/DU":;=0AEF]F@0 M-V.;9ED6^ZR=04\FBBK)X75P7"M9@S(,].X0>X%*03F-["CC,#8_:P5=6TA M'.GO'[Q+VPU V^GU[=YL^PD2YKFV$MJ>!(>U0_]P^P64;=NW%";8_] \)WG; MYBT%>,N^'?'.YA$KIE'XJ1)1?!2&F>=/POU!_<<4_+Z>-\F% M65A6M9=&.[DO^/#Z4.]BHT5!\%3._/IR:#7D#>85( M":<-;\_;_TY/TC;!<$";NRO>O[S6[SL7G ^L[\U9YS=02P,$% @ X#6> M7 F0'*D7" D$4 !0 !T:&,M,C R-C T,S!?9&5F+GAM;-V<;5/;N!;' MW_,I)IX[-V$Z!;W]E)^$A-H%& MHCO)&YHXBLY?YW^'>WOO_H70M_]\/1M\*-1L"GD]."Y!U* '-VD]&=03&/Q5E-_3'V)PGHG: M%.44HQ#2( M26!$]._Q00@R$8IP)+2*$04JD01-D4HT"Y.(15+RMM,LS;\?-'^DJ&!@AY=7 M[=OWPTE=7Q^,1CM MTKZ&MELR^O;I[$)-8"I0FE>UR-6# 6M>U_=??*R&C>8?VJ95>E"UWS\KE*A; M0"\.8?!LB^8=6C9#S25$ A22_=M*#P_W!H.YYT2IRB*#KV &BY=_?CWM*DWS M>J33Z6C19B2RS"IN>ZCOKN']L$JGUQDLKTU*,,^J7PZY$<4:.;\UO8V<-4VL MD%+-)"![%?(FQ#UJ[.O=7?-]7TB#$;.L]JBXV[=7O<54I#X=W.G:@]JV(S2% MJ832I]0G_3[2N12YJK#ILH8<[,(ILGJRKXKIJ%6X7%]%KD_R.JWO3O-F,6VG M__*SEX77$X6:U1;3$+<"7]7M(]TV0-(\;3X]LV\7?3<"WV($<&L[TC!?A98* MLD(]:90U:V!Q#RT3$K+VZI6&]*ICR-;.@>_UO;(0E$5@*XR&$^VQ[#(4UVW%/:&S&<34:W/W9%QHN ME!Y.H_#JRE\*ES%[9(D-0XG&) H( M)TPY3MM? /5)5OK A0+4!*S$#&EB332A#&\)GEH M.IPS;%X]0+PWY)-=7XZ[ L[!RX6+B[J,\*:,9A4:"W%]=5Q,IT5^41?J^Z=V MR)W8"SE*#"B;2%"B&'!@T;II9T0E6\<:W.?#^^?H,EX&5EM%F40IM?")5$)A ! MBR3>4OK/)%S_-/RU+GX+Z"]M1!$7B.N8HY@'6(1)&'*J=F=?]T7F9_?WM6Y] M@_SM O*T*#\7-53]@C"U"25E"H4)!WM9,BG79W.O+M&M$_.*L_8TJ MH!X=[7&^/\C[F&;P>=87DXJ)-KAM"A3CB!MA@*[;QE\+_<'BCA#>T(5O,JTO MQ>VIMOE(:M+Y7>I^850I)",9(-ISV4/PHZT+J&J M%O\TPR6='28*[7X%"I$$=!!RPF7,/1#O,;TCM%V=VB4=>B-];%]^*2^+FVY] M"=LS1L ETE%"<1BQF'N9V1W#NT5Y0X=V&5-OC-M5+7(_DZO^W)#G(1V6XDT8C%E MF!DN"/%QH[G/]F[AWMRM7=B1"^QFE3DJ0?3I:+(&SDR > CVV$]U B"<\#ZV MMO5 -W9=%V'L@K!Y^C,[GQ3Y,RD_$=JF_)0C'2AIA#V^8>7V,-"JQ:U'Z>3" M+D[N@O,"U*RT R2!O$SK[IT;'G-DOQ$B)150@XF4E#GA7+6X]3B=7-C%F;C@ MO"Q%\[#\Q=U4%EEG6X\52B(:(14&F'(%+,!N4_.)N:T'N;GS>DH93J6I94@M M;Z5_%M/NOBTYXHFBB# FDI@2%LG0R\Q\;'7KH3J[LH>M4YWJ+ZNFAKRY]3'+ M%W64SO"($DU2AA&7D8H3S6-"W)*A7K-;3]?=F3UXG0I2%T66JK1Y!NV3/6.5 MJ>BL) I3&VV2(8B4CL(H(%)(MXG;L;GU8!W=V$/5J?AT7D(38V /R\W=[LOF M%P+E%V-ZBI\X0=(>EQ&-1:"8"JB)W,H2S]O>>LJ>W-I#VZD,M2+KM*IF4*X1 MIZ1 P@"S"3L.14",QMIM1K^D8-?(N[FXA[^'FM3)%,JQ78#^6Q8W]<2JO1;Y MW:JN. !DT_H0!0Q'%%/0/%GW/,!KBU*]QK>>NB_']@!WJDO-=1W;0"Q%=FJ# M\/8/Z"BBVC09A#V6A4JYH/[BN,T\J&5E[W'>5H:)K? MY!,$AMI-(^2$:A^3]*G5K8?J[,H>MDZ%J^5O<2]MVU4A8!B2/&(H! ,$"XB8 MXQ[[V-K6L]S8=3V/8CA5K99"SNUYK= GN?Y@CVZ=.II)$(^E#2T9)5H%$!'9 M\T/W#6 ^,;LS5#=W9@_>1>'JW6C%*U;N]\.]Q>7F3_._7,QD\MQM# ]G, !0 !T:&,M,C R-C T,S!?;&%B+GAM;,6= M:V_;.!:&O_=7<+-88!O7OWR-PB__OO+.?@M3Q]F;%Z!DX*1BE'PF%5WH+ICX,^\ M^)[](.#SE%0\+V80OFO>=I+?/Q?9[5T%7,<-5\-6KQ9O'(13PE,'W;SR68)*B&!*:1M!G?@(31GV88AIX. S")(F;H--L M_OU-_2LXWF0U^F@Y_$D: M_^@UHQ'&>-*\NAY:9JJ!(BR:?/UT?I7>L1F!V;RLR#RM!9ZGI&JR MOG->H'-$_3^X&@;KIR!RH8>.GTIZ].X5 (MT%/F4?6$6L4Q)/ZA&3 M.;NM/]O/K,AR>E61HCHG"9N*V3?1JN=[]O:HS&;W4[9Z[JY@7!UV6A2MJ/4L M<3U+%-:S_'N7V&3 ]/ZQXFU]B]V-<<^W)ZL;?I7HM?"';X"6_(#)[R MX@MU.J=C?7?74H.G?O@9[^MKD5=D.L+7XD5F8\K3^HES\6@I4P?J^3%M=)8_ MW1M394\5FU.V^+5LA089?7LD'MT\E/"6D/N;DRDIRTM^5>7I]]_R&2;0)%3O)'^95\7R24[;-8>QRF#C,@PG"7NI$2>*XJ0Z'FGH'AG(Q M ]":PFO03$)D#2PG NJ9Z(&JF\9^:@^0'#.$]Y$7;:P-W2H8+UEZ?)O_F(A( M"[S%@Q>J=>./@KBAV17OIF^SA#]CY35)IA+FS(_$YB".( T2'(4X$%N/6N56 MBCP&T$(+?&O4-,NK[%^33QM7%B3J&#+';7OR]F"M(XV+T+8!"19I@&U-/,_* M*IO?EJ=/Z9WX=-C[IZS<9L3S14O*7"3^"#I\EV$<8;-2J)(9IP*NE%^#E3;X M5JN; J3.E&ZU&^K?JLB96[>H;'W.!A0T9=B1ZUB?-;E\]8XVPW/5 S=%L%XJ MW6R&5812+X(Q#WWHQC$-7#?@U ],-AH[E4;>=C0@2]#8@]V)]V';DGJ#4 M=K2GC<^(2A($HBE^GRTXI\Z*VU6DMLKBS5#)90VOYW(V/MRG!#3->0 M$2K*R5M1THXT&B!* YMLJ =88%'7JH(1Y0ZXB$-,20(IY0[C;IHP3WO5<3/P MH:%H.AJA9;@SK>5=@PA+1X9 Z)DQPT$Q=Y+-9 MO>LK3[]_8K.$%5*GY8E*X8H_'( 5H]9;K7,M)$V/#)&2 MHK>N-\BJ:1DQ<6E^5$B7DWT=%"+%'_>8D"Y[TB$AG0/-*\_[&9O3>@WPPY3< M;F.6!@C&'#G0H6Y(*6,N"I!NZ6E%/C!>:RU0B^G7GK;[W<7'VI,91YIVC*J/ M+0XNOWA05:*(!Y"D7@P93E% M$'=P$)JMMG4HC;/F)L1!6QTLY$W7W;KRI;OZMHD]MA4%Z9V_4&6VR_L-NLWAR;5ZH]3[&3P"3P,:0IHBR)'/''-:.U+3 . MI"^:AGN>E#G1)=+>J16(NB8M\%,[&4#=5L"185/;D1GK&&>.UG5!ZK/8KIYG M22ZM>M/8@]@)&>1A0CT7\\379ZH5^< P+;7 0DP?HK;[W?18>S+#1M..$2[* MJ5MQTHXT&B!* YMDJ >8(_&Y8/5F&!,SJEO.Z_K$E^*2<[E#3$3-B7$:B)6.AYR.=(:ZUQ'?' V%VP1_!7 M7GQ?+F^O#NK2X^W%=C]95F;,&+HX_1/\=?GE([BZOCSY"$Z_GOSG_<7OIZ_! MV<7)\1Y7[24K/=348YL>6 MDP8P<3B%(0U#)W4"[CNQT0'LVPH'IB(\CJ/@'V A"QI=0!\82R.S1G!+89P6<"D*&E4@9$V;O^V\Z+9] ]Q:-7SZ M1BU:O0XS YJ\[8@CMW<=AN3&KFN@+68?LBE3[R9SF -QZHI;[PC;RH$N4G3LKF'2,66 D.QA T$:PD>&1;W;&= M+EW*AB?!BC@+__8G>W28&W[&QW;@GW/:1X>]SG,_NL8/7O(_*\L'5O0L_*<. MJ0]2=,0&G<,BSGPG#;4/W-TE-O;R_V("^]D+(&?.>%_ H'P,W"-@DHHA.P8Z M/>YC]X <_&?M).BTV;.KH/L] ^OP\I_S;,[0-L^N@R!Q$88\\)$78,Q01*R* M\*;*R!5X^0#4VN!R;EN 6WDRK+ZV[H>57FWC]I5796QXV6U%_3DU5V6LL^ J M!P_$\G->5F3ZW^Q>>8(,32#!%,$@"0/"O<@EGN%N/)7,R& NM($0M[H8G3)1 MAF!:VQ]&IJYS>S"5QH:3V0[[<]!46NMD4SW:',X_BZRJV+PNR0_SY0&G[H,B=P!)C:E_E0*AP8R:4F:(OJDZC.RFX(!WLUX\_0IA%VO5:L MB%-'' VV7D.;G/4/-$>LOJ;]]/-=/N]8477KBPT@'T&/^#Q"!'NQKTW7=O # M@]7(@4;/>$55RL-NGH:X,T/)P)@11ET.K B2@HT&3Y>-36XZQUBTC,M#,M07 M%._*MLZ&;MA&6+1#!=3=U:78]NV,>A2;.M@HU^& M;=N&ZA)LTAAS>%:W:UK?H>0W4DD$42> L<\13%#JXL MV8BJ%Q+/*C:3UA>PY\/Z;#.(O 0G/$9!1+6.E>R7&6?=;T,9?*NU02-N?#5N M9:)TU_V&VK=:]S-V;G6;B6YC@^XNH0@[^DTENJVI[B71,]J^!EZ+MV[CB*(8 M$A;$D"(:(\=/$0^UE^$W X]5\6HM\S+76->O;J:&+(M:KQ>K2K8Y\4$%K DT M>MW:G+ZJ7+5>[P)A,Z,"G^_O7JV>R1:WB7SWZO]02P,$% @ X#6>7+S> M142W!P -4< !0 !T:&,M,C R-C T,S!?<')E+GAM;-68I2U3N'.[^]+1CZ/$4\?.R*; ?[^R(;SXYDDY,WOYVNTPG/\ 529X=3K#XA/?SM^ M\^;MWQ#Z^L\OYY-WN;Y>0E9.3AW($LSD)BD7DW(!DS]R]SWY(2<7J2QM[I8( M'==O.\U7=RZ9+\I)@(-H/6Q]UAUB(K2T&B,KC$&QH ()QB.D>1#3(":!E=$_ MYH'W1-,F^'U8/2A8P\>%E1?WR:+HH MR]7A;'9S/YY=Z 4N)DJPH9:8K T5R6-0'SW,MRUKU7_HU>7)$]0JMAZ'J$"(!"LG! M;6&FQV\FDWLY7)["%["3ZN_O7\XV3):0@<^?3,O%@^6@J(97Y\_]@8>K5RZ^1@QPZR]DX%ZYM0]IKC<&I57>Y_S"=J*)T4I??MM@F_D%@")$@4E$14$V(WI2L"JKP4=5I+D ?S/,?,W]A MG^Z 5D\J06DM9L/1_: MW6?&^SN=^+ M. ?F_#XQ3T97AU;ZB@WUR,Y)OSM/BM*7^^+]K5[(; XGMTFQ M'84A/HJ88,0$C[ B$BMINQ.PT_9P.'1(Y#8.W54=FHT'O]_E2YEDVYXSYJ?? MV#(D#"910#AANB,/&_8&9J"'[.6]2#D@!."]_O;UTW\NMQW6+$ B9B%BVA!E ME0UC"%KDOKK@??*K9S^S_Z>A 9/>(4-Y%[D&S.]U@>92KOPEL7ZR,_'?==3QI>##.Y])S>[?K23>LQT/*K M"AEQB;B).8IY@&4HPI#3Y[;,_[_)Y]58Z9K5OSH)/2OQ"!BYA"S)W:>\A&)W M )CZ%19E&H6"@S]LN"9QWY//MA/#3#JOQ$@WB8?>J6XW]\Z3#,Y\N6T45Q7% M/@H)B(38,FQ5$.,V.Y=?=3%VV6[%1SC.14F/JHZ$#9V[5>[J..JI^#2_SDIW M=YJ;AD):*R1(K)%F& +_DE'YW%*V/23/.#%TOZ-[GG>@TY?HHV#H0Y+"I^M= MM5$S61=99"#&$;?2 GUN/=L6F)\6!][@O 8=+Y1S%"AV#BR?,#SSAO 8D?0@]"F).C/'Y*![^5/*0Q@HK"OUZ M#30B DP02T5I&&Y%"-M'0EXH[ICXJ-=2G]V%RW\DF6XLI4*ND<211 HK9B4(4,^V M8O\B)%O66Y$2[2,I760>$RX7>5'*]+_):M>Z&XO03YV102RF##/+)2%]?*^_ MRW8K5.)]1.7E$@\,2E4-3QS(77Y7JRK.;(!X"!&7U @ V>UFI4?66L' ]P2& M%\LX/;$5(]+XK1CER 1:6>FWY%AWN^]KVV(K#,2>8-!)SH%1 MN 1][;P@)%!72=GL&_*8(_^.$&FE@5I,E**L$PK;%MNUP/">L-!)SX%9N'*R MNO_[\FZI\K2Q[HDU$A&-D X#3+D&%N!N-6'#7#L*]J43^G(E1U(.UC?#?)++ MYL)&<<2%IH@P)D5,"8M4V$M)>&RU'1#[TOSLK.O 7/SAG2\AJ[Y3OLX>FG(- M-8B6U8H7(ZXB'0O#8T*ZK1QWFFU'QKYT/+LK.W3)R--$)]5=LQ_]QMDELE'P M-*8>;,401-I$8100)56W@M&PV0Z*?6EN=M1T8"(N'%0X0Z;K6Y^NJO^M<9^M MW='!QP(IY4L>C66@F0ZHC;KUK)ZVW8Z0?6EN]J3QN$@Y*XIK<,_$HI5$T@+S M.RDN9YO_TW- *@ MQE8++(X,IT$0R9@HW 5/\1G)6[=N2$FCZ*PZ;5=G=\[4LSM+.N W.Q_K6 *S]VVV^P#"D>,11ZOPB6$+&.:XK' MUMIQL"_MT!?K.)+\7_@M>&[>9^:=WXTWVKE6(!XK3[&*A-$!1$1!+R!LF&U' MQ+[T0[LKVQL:;V<-17U\WX_?/)RH'JI?63E^\S]02P$"% ,4 " #@-9Y< MX>-;'9ID (Q0< '@ @ $ =&AC+3(P,C8P,S,Q97@Y M.3%E87)N:6YG7'(7Q^51$ D'8 ! M ( !UF0 '1H8RTR,#(V,#0S,"YH=&U02P$"% ,4 " #@ M-9Y- L !T:&,M,C R-C T,S!?<')E+GAM;%!+!08 !@ & (X! E0 ! end XML 17 thc-20260430_htm.xml IDEA: XBRL DOCUMENT 0000070318 2026-04-30 2026-04-30 0000070318 us-gaap:CommonStockMember exch:XNYS 2026-04-30 2026-04-30 0000070318 us-gaap:SeniorNotesMember exch:XNYS 2026-04-30 2026-04-30 0000070318 false 8-K 2026-04-30 TENET HEALTHCARE CORP NV 1-7293 95-2557091 14201 Dallas Parkway Dallas TX 75254 469 893-2200 false false false false Common stock, $0.05 par value THC NYSE 6.875% Senior Notes due 2031 THC31 NYSE false 2026-04-30 2026-04-30